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1. Summary 
The eukaryotic cytosolic chaperonin TRiC is a hexadecamer consisting of two eight-membered 
rings that are stacked back to back. Each ring forms a central cavity, which is large enough to 
accommodate proteins up to 70 kDa according to structural studies. TRiC supports folding of its 
substrates by ATP-dependent rounds of binding, encapsulation and release. Surprisingly, one 
third of the known TRiC interactors exceed the size of the TRiC cavity. In the present work, 
experimental evidence for partial encapsulation of large substrates inside the central TRiC cavity 
is presented. 
The cytoskeletal protein actin is a well-described obligate TRiC substrate. Upon in vitro 
translation in rabbit reticulocyte lysate, fusion proteins containing actin and GFP or actin, GFP 
and BFP connected by flexible linkers were used as model multi-domain proteins containing a 
TRiC dependent domain. Folding of actin was monitored by specific binding to DNase I as well 
as by occurrence of a protease-resistant actin fragment that derived from native actin. Folding of 
actin was impaired but not prevented by fusion with GFP. Interestingly, folding of actin was 
more severely impaired by fusion of GFP to its C-terminus (AG) than by fusion of GFP to its N-
terminus (GA), suggesting that flexibility of the actin C-terminus is important for actin folding. 
Folding of actin was prevented by simultaneous fusion of BFP to the N- and of GFP to the C-
terminus of actin (BAG), apparently due to steric problems hindering partial encapsulation. 
Folding of actin was possible when both BFP and GFP were fused to the actin N-terminus 
(BGA), even though the resulting polypeptide had a molecular weight of almost 100 kDa, 
indicating that TRiC-dependent folding of large multi-domain proteins exceeding the size of the 
TRiC cavity is possible. 
Proteinase K treatment in presence of ATP and AlFx, resulting in a stably closed state of TRiC, 
was used to probe which parts of the actin fusion proteins were encapsulated inside the TRiC 
cavity. Protection of the full-length proteins against proteolysis was observed in case of the 
smaller actin fusion proteins GA and AG upon closure of the TRiC cavity by ATP and AlFx. 
However, full-length BAG and BGA were not protected. Instead, the largest stable fragment of 
BGA had the same apparent molecular weight as GA, suggesting that cleavage occurred in the 
linker region between BFP and GFP and that the linker was probably located outside TRiC after 
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closure of the cavity. Interestingly, no protected fragment of BAG was detected, indicating that 
this particular fusion protein was not encapsulated, explaining its inability of being folded. 
Furthermore, PK protection experiments indicated that the spliceosomal protein hSnu114 (109 
kDa), a previously reported naturally occurring TRiC interactor, is also partially encapsulated 
inside the TRiC cavity. hSnu114 is likely a complex multi-domain protein with structural 
homology to eEF2, for which crystal structures are available. Several fragments of 15-45 kDa are 
protected by TRiC from PK digest in presence of ATP and AlFx. All these fragments include the 
C-terminus of the protein as inferred from protection of C-terminally HA-tagged fragments of 
comparable sizes derived from hSnu114-HA. Surprisingly, when the C-terminal part of hSnu114 
(hSnu114-C, 45 kDa) was expressed separately, no smaller protected fragments were observed 
and instead the complete hSnu114-C was encapsulated inside the TRiC cavity. 
The occurrence of several fragments of different sizes indicates heterogeneity of TRiC-hSnu114 
complexes with regard to the encapsulated part of hSnu114. Furthermore, the observed protected 
segments were much smaller (15-45 kDa) than the size of the TRiC cavity (up to 70 kDa), 
suggesting that TRiC might preferentially encapsulate only the TRiC-dependent domain(s) and 
might exclude the rest of the protein. How TRiC recognizes domain boundaries is not clear. 
However, the absence of smaller protected fragments in absence of the N-terminal part of 
hSnu114 (hSnu114-N) suggests that hSnu114-N plays an important role in the selection of which 
parts of the C-terminal region of hSnu114 will be encapsulated, even though hSnu114-N itself 
appears to be TRiC-independent. Rather, it appears that interactions between the N- and C-
terminal parts of the protein guide proper binding of hSnu114 to TRiC and subsequent domain-
wise encapsulation. 
Taken together, these experiments provide evidence for partial encapsulation and folding of large 
proteins by TRiC, allowing a mechanism of domain-wise folding. This mechanism, which is not 
accessible to the prokaryotic chaperonin, may have facilitated the evolution of multi-domain 
proteins, a class of proteins highly prevalent in eukarya. 
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2. Introduction 
2.1 Protein Folding 
 Proteins Consist of Amino Acids Connected by Peptide Bonds 2.1.1
The genetic information encoded in the DNA is eventually transformed into the linear amino 
acid sequence of a polypeptide after transcription into mRNA and translation thereof at the 
ribosome. The translation of an mRNA sequence into an amino acid sequence is determined by a 
universal genetic code. 64 different codons exist, 61 of which code for the 20 different canonical 
proteinogenic amino acids. The remaining three codons are stop codons that lead to stop of 
translation and release of the polypeptide from the ribosome. Additionally, two of the stop 
codons encode for two non-canonical proteinogenic amino acids, selenocysteine and pyrrolysine. 
Selenocysteine containing proteins are found in all kingdoms of life. However, only few proteins 
contain selenocysteine (e.g. 25 proteins in humans), mostly proteins involved in redox reactions 
(Mariotti et al., 2012). Pyrrolysine is not found in eukaryotes but only in a few archaeal and 
prokaryotic enzymes required for production of methane from methylamines (Krzycki, 2005). 
Proteinogenic amino acids consist of an amino group and a carboxyl group, which are both 
connected to the same Cα carbon atom (Figure 1). This carbon is furthermore bound to a 
hydrogen atom and to a side chain R, which differs between different amino acids and confers 
the individual chemical properties to the amino acid residues in a polypeptide chain. The side 
chains can be as small as a single hydrogen atom in case of glycine; there are positively or 
negatively charged side chains as well as aliphatic and aromatic side chains. More than half of 
the side chains of proteinogenic amino acids contain hetero-atoms beside carbon and hydrogen 
such as oxygen, nitrogen or sulfur. 
The peptide bond between individual amino acids is formed by a condensation reaction between 
the amino group of one amino acid and the carboxyl group of another one (Figure 1). As the 
peptide bond has a partial double bond character (Pauling et al., 1951), the rotation around the 
peptide bond is strongly restricted and the adjacent groups practically exist only in two 
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conformations called trans and cis. The trans conformation is energetically favored and therefore 
less than 0.5% of the peptide bonds in native proteins are found in the cis conformation (Weiss et 
al., 1998). An exception is the peptide bond preceding proline residues, which occurs in the cis 
conformation in approximately 5% of the cases in native proteins (Weiss et al., 1998).  
 
The polypeptide backbone contains two other kinds of bonds in addition to the peptide bond that 
connects the different amino acids, namely the bonds connecting Cα with the amide nitrogen and 
the carbon atom of the carbonyl group, respectively. The angle between the groups of the N-Cα 
bond is usually termed φ and the angle between the groups of the Cα-C bond is called ψ. In 
principle, a free rotation around these two bonds is possible. However, steric constraints lead to a 
constriction of the energetically stable combinations of φ and ψ (Ramachandran et al., 1963). In 
addition to the conformation of the peptide bonds (cis or trans) the different values for φ and ψ 
define the backbone conformation of the polypeptide. In order to describe the entire 
conformation of the protein, the different conformations of all side chains have to be considered 
as well. Thus, there is an almost unlimited number of conformations even for small proteins and 
Figure 1: Simplified scheme of peptide bond formation. Top: Two amino acids with different side 
chains Ra and Rb are shown on top. Note that elongation of polypeptide chains at the ribosome occurs 
with amino acids activated by ester formation with the 3'-OH of tRNA. Bottom: The peptide bond 
is shown in red. Partial double bond character is indicated by dashed line. The angles φ and ψ 
defined by rotation around the N-Cα and the Cα-C bond, respectively are indicated in green. 
- 8 - 
 
the question arises of how an unfolded polypeptide chain can find its unique native and 
biologically active conformation. 
 
 The Thermodynamic Hypothesis 2.1.2
In 1972, Christian Anfinsen was awarded the Nobel Prize in Chemistry for his “studies on 
ribonuclease, in particular the relationship between the amino acid sequence and the biologically 
active conformation” (Anfinsen, 1973). His experiments were supporting the so-called 
“thermodynamic hypothesis”. According to this postulate, the native three-dimensional 
conformation of a protein is the one with the lowest free energy. This means that the native state 
of a protein is solely governed by its inter-atomic interactions and thus by its amino acid 
sequence and is not dependent on other cellular components (Anfinsen, 1973). 
 
The bovine pancreatic ribonuclease is a protein of 154 amino acids which has four intra-
molecular disulfide bonds (Anfinsen, 1973). It was used in the 1950s and 1960s by many protein 
chemists for their experiments simply because it was available to them in large amounts 
(Richards, 1992). Anfinsen and his colleagues had denatured the protein in 8 M urea and reduced 
Figure 2: Scheme of experiments performed by Anfinsen and colleagues with ribonuclease; adapted 
from Anfinsen, 1973. 
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the disulfide bonds with β-mercaptoethanol. Re-oxidation in the presence of urea resulted in the 
formation of non-native disulfide bonds and hence non-native and inactive ribonuclease. 
However, when the urea was removed and exchange of the disulfide bonds was enabled by 
addition of a small quantity of β-mercaptoethanol, the different non-native conformations were 
eventually converted into a homogeneous population of native ribonuclease (Figure 2), 
indicating that formation of the native state was not dependent on any external factors but was 
indeed determined by the amino acid sequence only (Anfinsen, 1973; Anfinsen et al., 1961). This 
statement holds in principle true also today, more than fifty years after Anfinsen’s 
groundbreaking experiments. 
 
 Thermodynamics and Kinetics of Protein Folding 2.1.3
Even though folding is a specific process that differs not only between different proteins but also 
between the different unfolded states of one particular protein, several common principles have 
been postulated and confirmed experimentally. The energy landscape of a protein folding 
reaction is commonly depicted as a funnel, in which the thermodynamically stable native state is 
represented as the narrow bottom of the funnel while the unfolded state ensemble is represented 
as the broad edge at the top of the funnel (Dill and Chan, 1997). Any given point at the surface of 
the funnel depicts a particular conformation of the protein. Minimization of free energy drives 
the protein into the native conformation. Which are the factors that contribute to the low free 
energy of the native state? 
The native state of most proteins is only marginally energetically stable (Dill et al., 2008). 
Several factors contribute to overcompensate the loss of entropy compared to the unfolded state 
ensemble. The most important factor seems to be the energetically favorable burial of 
hydrophobic side chains in the interior of the protein (Dill et al., 2008). Many proteins have a 
hydrophobic core, from which the surrounding aqueous solvent is excluded. Instead, polar and 
charged amino acid residues tend to cover the protein surface and increase the solubility of the 
respective protein by favorable interactions with the solvent. Another important factor 
contributing to protein stability is intramolecular hydrogen bonding (Dill et al., 2008). In fact, in 
folded proteins almost every amide and carbonyl group of the polypeptide backbone is involved 
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in hydrogen bonds that stabilize secondary structure elements such as α-helices or β-strands. 
Also salt bridges between charged side chains contribute to protein stability. 
The transition from the unfolded state ensemble to the native state is governed by 
thermodynamic parameters and is a reversible process. The kinetics of folding depend on the 
energy landscape of the folding reaction (Dill and Chan, 1997). In the simplest case, an unfolded 
protein is converted into the native state without the population of kinetically stable 
intermediates. However, not all protein folding reactions can be described as a simple two-state 
process. A more complicated scenario occurs when local energy minima exist on the way from 
the unfolded ensemble to the folded state. In this case, intermediate conformations are actually 
populated. A high energy barrier between the transition state ensemble and the native state slows 
down the folding process and can result in kinetically trapped intermediates that prevent the 
efficient accessibility of the native state (Baker and Agard, 1994; Kiefhaber, 1995). Furthermore, 
as long as a protein has not yet reached its native state, non-native intermolecular interactions 
can lead to the formation of protein aggregates (Dobson, 2003). 
 
 
2.2 Molecular Chaperones Assist Protein Folding in the Cell 
 Many Molecular Chaperones are Heat Shock Proteins 2.2.1
The initial research on protein folding was carried out by refolding isolated and diluted small 
proteins in vitro. However, refolding experiments might only partially reflect the situation of de 
novo protein folding in the cell where co-translational folding during protein biosynthesis at the 
ribosomes plays a major role (Kramer et al., 2009). Additionally, protein folding in living cells is 
challenged by high intracellular macromolecule concentrations which favor non-native contacts 
of unfolded polypeptides (Ellis, 2001). Therefore, an elaborate molecular machinery has evolved 
throughout all three domains of life, which ensures that protein misfolding and aggregation is 
minimized and that protein folding to the native state occurs at a biologically relevant time scale 
(Hartl et al., 2011; Hartl and Hayer-Hartl, 2002). In fact, a sophisticated network of different 
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classes of proteins, termed molecular chaperones (Ellis, 1987), exists that accompanies a newly 
made protein from its formation at the ribosome until it has reached its native state (Figures 3 
and 4). 
 
Many molecular chaperones are heat-inducible and they have thus originally been called “Heat 
shock proteins” (Hsps) (Lindquist and Craig, 1988; Schedl et al., 1978). In fact, various stress 
conditions lead to protein unfolding and the induction of Hsps during stress is highly important 
to deal with the increased load of unfolded proteins (Hageman et al., 2007). Heat shock proteins 
have been historically classified according to their rough molecular weight. The major groups are 
Figure 3: Simplified scheme of chaperone pathways in prokaryotes adapted from Hartl and Hayer-
Hartl, 2002 and from Hartl et al., 2011 
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small Hsps, Hsp40s, Hsp60s, Hsp70s, Hsp90s, Hsp100s and Hsp110s. Next to their role in 
dealing with unfolded proteins under stress conditions, different Hsps co-operate with other 
molecular chaperones in folding newly synthesized proteins along chaperone pathways in the 
cytosol (Hartl et al., 2011). Additionally, organelle-specific chaperones assist folding of their 
substrates within different organelles. 
 
 
 
Figure 4: Simplified scheme of chaperone pathways in the eukaryotic cytosol adapted from Hartl and 
Hayer-Hartl, 2002 and from Hartl et al., 2011 
- 13 - 
 
 Pathways of de novo Protein Folding in the Cytosol 2.2.2
A nascent polypeptide chain that emerges from the ribosomal exit tunnel is first recognized by 
ribosome-associated chaperones (Kramer et al., 2009), trigger factor (TF) in bacteria (Ferbitz et 
al., 2004) and nascent-polypeptide-associated complex (NAC) (Rospert et al., 2002) as well as 
the ribosome-associated complex (RAC) (Gautschi et al., 2001) in eukaryotes. Both TF and NAC 
work independently of nucleotides, but they do not share structural similarities. TF interacts with 
the ribosome as a monomer and the affinity of TF for the ribosome is drastically increased by 
ongoing translation and thus by the presence of a nascent chain, in which TF interacts with 
hydrophobic patches (Kaiser et al., 2006). NAC exists as a hetero-dimer and interacts with the 
ribosome via its β-subunit (Rospert et al., 2002). The mechanism of action of NAC is not well 
understood. In contrast to TF and NAC, RAC includes ATP-dependent molecular chaperones. In 
yeast, RAC consists of the Hsp70 protein Ssz1 and the Hsp40 protein zuotin that build a stable 
hetero-dimeric complex (Gautschi et al., 2001). RAC stimulates the ATPase activity of Ssb1/2 
(Huang et al., 2005), another ribosome-associated Hsp70 chaperone that directly contacts nascent 
polypeptide chains (Gautschi et al., 2002). 
 The interaction with Hsp70 is not sufficient for all proteins to reach the native state. Hsp90 and 
the Hsp60s, the latter also referred to as “chaperonins” (Hemmingsen et al., 1988), are 
specialized downstream chaperones that mediate folding of those proteins (Figures 3 and 4). The 
chaperonins are large ring-complexes that function as a cage for single protein molecules to fold 
unimpaired by aggregation. The mechanism of substrate delivery from Hsp70 to the downstream 
chaperones is not entirely understood. Nevertheless, some details are known about the respective 
chaperone pathways. For example, Hsp70 and Hsp90 interact via an adaptor protein called Hop 
that binds to both chaperones (Wegele et al., 2004). Transfer of substrates to the eukaryotic 
chaperonin TRiC (for TCP-1 Ring Complex, also called CCT for Chaperonin Containing TCP-1) 
seems to be mediated by the hexameric chaperone prefoldin (PFD) that was shown 
biochemically and structurally to be involved in delivery of actin and tubulin to TRiC (Hansen et 
al., 1999; Martin-Benito et al., 2002; Vainberg et al., 1998). However, a cryo-EM structure of the 
nucleotide-binding domain of Hsc70 in complex with TRiC suggests that transfer might be 
enabled also by a direct interaction between Hsp70s and TRiC (Cuellar et al., 2008). 
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2.3 Different Classes of Molecular Chaperones 
The different classes of molecular chaperones are very diverse with regard to their structure. 
Hsp60s, Hsp70s and Hsp90s undergo ATP-dependent conformational changes that drive 
substrate binding and release. Other molecular chaperones like small Hsps as well as the 
ribosome-associated chaperones trigger factor and NAC work independently of ATP. 
 
 Small Heat Shock Proteins 2.3.1
The most prominent representative of small Heat shock proteins is α-crystallin, a major 
component of the eye lens (Horwitz, 2003). Small Hsps are generally characterized by the 
presence of an α-crystallin domain that is flanked by poorly conserved N- and C-terminal 
extensions (Sun and MacRae, 2005). The molecular weight of small Hsp monomers is low 
(approximately 10-40 kDa) but they assemble into large oligomeric complexes of up to 1 MDa. 
Small Hsps bind unfolded proteins and prevent their aggregation (Sun and MacRae, 2005). 
However, small Hsps do not actively refold denatured proteins; they rather keep their substrates 
in a folding competent state (Sun and MacRae, 2005). 
 
 Hsp70 2.3.2
Hsp70s are perhaps the most well-known group of all molecular chaperones. They consist of an 
N-terminal nucleotide-binding domain (NBD) of 45 kDa and a C-terminal substrate-binding 
domain of 25 kDa (Figure 5). The substrate-binding domain cycles between an open and a closed 
conformation depending on the nucleotide state of the NBD. In the ADP-bound conformation the 
lid over the substrate-binding domain is closed and Hsp70 forms a stable complex with its 
substrate (Mayer and Bukau, 2005). The ATPase cycle of Hsp70s is regulated by ATPase-
activating proteins on the one hand and by nucleotide exchange factors (NEFs) on the other 
hand. NEFs catalyze the exchange of ADP for ATP, which results in an opening of the substrate-
binding domain (Figure 5) and substrate release. Substrates that still expose hydrophobic patches 
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after release will rebind to Hsp70. The ATPase activity of substrate-bound Hsp70s is stimulated 
by Hsp40s that are also called J proteins following the bacterial Hsp40 DnaJ (Walsh et al., 2004). 
 
 
 Hsp70 Co-Chaperones 2.3.3
In bacteria, the NEF GrpE catalyzes the release of ADP from DnaK, thereby indirectly opening 
up the DnaK substrate-binding domain and enabling another cycle of substrate binding and 
release (Harrison et al., 1997; Packschies et al., 1997). The mammalian Hsp70s display a higher 
intrinsic dissociation rate of ADP than DnaK and can consequently function without a nucleotide 
exchange factor (Mayer and Bukau, 2005). However, their ADP release rate can also be 
increased by interaction with different structurally unrelated Hsp70 NEFs, namely BAG domain 
proteins (Hohfeld and Jentsch, 1997), HspBP1 homologs (Kabani et al., 2002) and Hsp110 
proteins (Polier et al., 2008). 
BAG-1 plays also a major role as a co-chaperone in chaperone-assisted protein degradation. This 
pathway leads to transfer of Hsp70 substrates to the proteasome or the lysosome. BAG-1 in 
conjunction with the chaperone-dependent ubiquitin E3 ligase CHIP connects Hsp70 with the 
ubiquitin-proteasome system. Different co-chaperones exist that link Hsp70 with the autophagy-
Figure 5: Simplified scheme of nucleotide-dependent changes in the substrate-binding domain of 
Hsp70s adapted from Hartl et al., 2011. The nucleotide-binding domain is shown in green. The 
substrate-binding β-sandwich domain is shown in turquoise and the α-helical lid is shown in yellow. 
An unfolded substrate is shown in red, exposing a stretch a hydrophobic amino acids shown in orange. 
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lysosome pathway (Kettern et al., 2010). Another Hsp70 co-chaperone called Hip stabilizes 
Hsp70 in the ADP-bound closed conformation (Hohfeld et al., 1995). Finally, Hsp110s are 
Hsp70 homologs that function as NEFs for Hsp70s (Polier et al., 2008; Schuermann et al., 2008; 
Shaner and Morano, 2007). Additionally, Hsp110 binds unfolded proteins and prevents their 
aggregation (Oh et al., 1997). However, refolding of denatured proteins cannot be achieved by 
Hsp110 alone. Instead, cooperation of Hsp110 with Hsp70 is required for refolding (Oh et al., 
1997). 
 
 Hsp90 2.3.4
Hsp90 is a dimer in solution (Wandinger et al., 2008). In contrast to other molecular chaperones, 
Hsp90 has a fairly specialized and well defined set of substrates that fall mainly into the two 
major classes of signaling kinases and transcription factors, especially steroid hormone receptors 
(SHRs). Kinases and SHRs are transferred from Hsp70 to Hsp90 when both chaperones become 
connected by the co-chaperone Hop (Caplan et al., 2007; Wandinger et al., 2008). Hsp90 has 
moved into the focus of cancer research in the last decade because many of its substrates are 
signaling kinases that play important roles in the development of cancer. Small molecule 
inhibitors of the Hsp90 ATPase activity such as geldanamycin have an anti-tumor effect because 
inhibition of Hsp90 leads to degradation of the Hsp90 substrate proteins (Maloney and 
Workman, 2002). 
 
 Hsp100 2.3.5
The classes of molecular chaperones described above share a common function in preventing 
protein aggregation and assisting protein folding. In contrast, Hsp100 proteins come into play 
when protein aggregation has already occurred. They function as “disaggregases” and re-
solubilize aggregated proteins in an ATP-dependent manner (Zolkiewski et al., 2012). Hsp100 
proteins belong to the class of AAA+ ATPases. They form hexameric rings and re-solubilize 
aggregated proteins by threading them through the central pore of the hexamer (Zolkiewski et al., 
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2012). Interestingly, Hsp100 proteins are found in bacteria (ClpB), yeast (Hsp104) and plants, 
but not in animal cells (Zolkiewski et al., 2012). 
 
 
2.4 The Chaperonins 
The chaperonins, also known as Hsp60s, are a class of evolutionary conserved molecular 
chaperones found in all domains of life. Chaperonins assemble into large oligomeric double-ring 
complexes whose rings are stacked back to back. The chaperonin monomers consist of three 
domains (Figure 6). The equatorial domain contains the ATP-binding site. The intermediate 
domains connect the equatorial domains with the apical substrate-binding domains, which are 
located at the ends of the double-ring complex (Braig et al., 1994). Folding of the substrate 
proteins is achieved upon encapsulation within the central cavity formed by one ring. Opening 
and closing of the cavity are driven by ATP binding and hydrolysis. 
 
 Differences between Group I and Group II Chaperonins 2.4.1
Chaperonins can be divided into two different groups (Kim et al., 1994). Group I chaperonins are 
found in bacteria (GroEL) and in organelles of prokaryotic origin, i.e. chloroplasts (Cpn60) and 
mitochondria (Hsp60). The best studied group I chaperonin is the tetra-decameric GroEL from E. 
coli. GroEL encapsulates its substrates with the help of the co-chaperone GroES (Hsp10). Homo-
heptameric GroES serves as a lid that closes the GroEL cavity (Saibil, 1996). Group II 
chaperonins exist in the cytosol of archaea (Thermosome) and eukaryotes (TRiC). Structural 
studies have shown that they are independent of a GroES-like co-chaperone. Instead they have a 
built-in lid (Ditzel et al., 1998). The two groups of chaperonins differ in the inter-ring 
arrangement. While a single GroEL subunit contacts two subunits on the opposite side of the ring 
(Braig et al., 1994), in group II chaperonins each subunit contacts only one subunit across the 
ring (Ditzel et al., 1998; Gutsche et al., 1999). 
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Another major difference between group I and group II chaperonins is the ATP-dependent 
rearrangement of the individual subunits that characterizes the cycles of opening and closing. 
The equatorial domains do not have high flexibility in group I chaperonins because of the 
staggered inter-ring arrangement. Thus, essentially only the intermediate and the apical domains 
move during ATP-driven cycling. Upon ATP-binding, the intermediate domain rotates 
downward by approximately 25°, thereby closing the ATP binding pocket. This movement 
induces and enables a clockwise rotation and a large upward tilt of the apical domain that is 
stabilized by binding of GroES (Ma et al., 2000). A stably closed GroEL/ES complex can be 
obtained by incubation with non-hydrolysable ATP analogs, AMP-PNP or ATPγS, indicating 
that ATP-binding to GroEL is sufficient to induce stable binding of GroES to GroEL. 
Figure 6: Comparison of single subunits of group I (GroEL/ES) and group II (TRiC) chaperonins. 
PDB files of respective crystal structures ((3P9D, Dekker et al., 2011) and (1AON, Xu et al., 1997)) 
have been modified using PyMOL (DeLano Scientific). The design of this figure was inspired by 
Gutsche et al., 1999. The subunits are not drawn to scale. 
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Interestingly, the large movements of the apical domains are only easily achieved when all the 
subunits in the ring move in a concerted manner. Otherwise, sterical clashes would interfere with 
domain movement (Ma et al., 2000). 
 
 
In group II chaperonins the movements that are induced by ATP binding and hydrolysis are 
entirely different. ATP binding results in a 45° counterclockwise rotation of the apical domain. 
Upon ATP hydrolysis the entire subunit moves towards the center of the cavity by a large 
rocking motion hinged in the equatorial domain (Zhang et al., 2011). Thus, a stably closed group 
II chaperonin complex cannot be obtained by non-hydrolysable ATP analogs. Instead, a stably 
closed complex is achieved experimentally by analogs of the transition state of ATP hydrolysis, 
usually generated by incubation with ADP or ATP and aluminum fluoride (AlFx) (Chabre, 1990; 
Martin, 1988; Meyer et al., 2003). There are no structural constraints that would suggest that a 
concerted closure of the cavity would be preferred. Rather there is genetic and structural 
Figure 7: Structural comparison of group I (GroEL/ES) and group II (TRiC) chaperonins. PDB files of 
respective crystal structures ((3P9D, Dekker et al., 2011) and (1AON, Xu et al., 1997)) have been 
modified using PyMOL (DeLano Scientific). The design of this figure was inspired by Gutsche et al., 
1999. The complexes are not drawn to scale. For better understanding one subunit of each complex 
was colored by domains using the same color code as in Figure 6. The other subunits are shown in 
blue. GroES and the helical protrusion region of TRiC were colored in brown. 
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evidence for a sequential mechanism of ring closure in group II chaperonins (Lin and Sherman, 
1997; Rivenzon-Segal et al., 2005). 
 
 Structural Characterization of Chaperonins 2.4.2
Chaperonins work as allosterically regulated “two-stroke” machines (Xu and Sigler, 1998), 
exhibiting negative cooperativity in ATP binding and hydrolysis between the two rings (Yifrach 
and Horovitz, 1995) thereby generating asymmetric complexes (Langer et al., 1992) with one 
ring closed (cis ring) and the other ring open (trans ring) during the functional cycle. Such a 
“bullet-like” (Ishii et al., 1992) complex has been characterized structurally at high resolution for 
the bacterial group I chaperonin GroEL (Xu et al., 1997) (Figure 7). The first crystal structure of 
a group II chaperonin was that of the symmetrically-closed thermosome from the archaeon 
Thermoplasma acidophilum (Ditzel et al., 1998). Structure determination of the eukaryotic group 
II chaperonin TRiC has proven to be more difficult. However, now crystal structures of TRiC in 
the open (Munoz et al., 2011) and in the closed (Dekker et al., 2011a) conformation as well as a 
high resolution cryo-EM structure of closed TRiC (Cong et al., 2010) are available. Additionally, 
the hexadecameric group II chaperonin from Methanococcus maripaludis (Mm-cpn) has gained 
attention for structure determination because its homo-oligomeric nature makes it a useful tool 
for introducing and studying point mutations and deletions. The open and the closed states have 
both been characterized by crystallography (Pereira et al., 2010) as well as cryo-EM (Zhang et 
al., 2010). 
All the above mentioned structures show group II chaperonins in a symmetric conformation with 
either both rings closed (Figure 7) or both rings open. Structural indications for an asymmetric 
TRiC complex came mainly from low resolution cryo-EM (Llorca et al., 1999b) and small angle 
X-ray scattering (SAXS) (Meyer et al., 2003) data. Asymmetric structures of archaeal group II 
chaperonins have also been described (Clare et al., 2008; Schoehn et al., 2000). However, the 
observed negative cooperativity between the two rings suggested that the asymmetric complex 
might represent the physiologically more relevant conformation (Kafri et al., 2001; Reissmann et 
al., 2007; Yebenes et al., 2011). Finally, an asymmetric TRiC complex has recently been 
characterized structurally by symmetry-free cryo-EM reconstruction (Cong et al., 2011). The 
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asymmetric TRiC complex had been obtained by incubation with ADP and AlFx as described 
earlier (Meyer et al., 2003). 
 
 The Intra- and Interring Arrangement of TRiC Subunits 2.4.3
It is widely accepted that the individual TRiC subunits arrange in a fixed and unique orientation 
within one ring as well as between the rings. However, the exact intra- and inter-ring 
configuration was unclear during the last decade. Early experiments inferred the intra-ring 
subunit orientation from TRiC “micro-complexes” of 60-250 kDa that occurred upon sucrose 
density centrifugation and that had different subunit compositions (Liou and Willison, 1997). 
Based on cryo-EM structures of TRiC in complex with subunit-specific antibodies, an inter-ring 
orientation has been hypothesized under the assumption that the originally proposed intra-ring 
orientation was correct (Martin-Benito et al., 2007). Two recent higher resolution cryo-EM and 
crystal structures, which are not consistent among themselves, have challenged the original 
model (Cong et al., 2010; Dekker et al., 2011a). However, the limited resolution of both data sets 
has prevented an unambiguous assignment of the different subunits. In any case, the two-fold 
symmetry observed in both data sets clearly suggested two homotypic inter-ring contacts 
(Figure 8) at opposite sides of the ring, which has not been predicted by the earlier model. The 
definite intra- and inter-ring order of subunits was finally inferred from mass spectrometry 
detection of cross-linked peptides of different subunits (Kalisman et al., 2012; Leitner et al., 
2012). The proposed subunit order differs from all previously suggested orientations, but has two 
homotypic inter-ring contacts as previously suggested. The fact that the same order of subunits 
has been found independently for both bovine and yeast TRiC makes it likely that the correct 
subunit order has been finally detected. 
 
 TRiC Co-Chaperones 2.4.4
For the eukaryotic chaperonin TRiC, several co-chaperones have been described that co-operate 
with TRiC. Delivery of the cytoskeletal proteins actin and tubulin to TRiC has been reported to 
be achieved by a hexameric jellyfish-like complex called prefoldin (Hansen et al., 1999; Martin-
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Benito et al., 2002; Siegert et al., 2000; Vainberg et al., 1998). Another group of TRiC co-
chaperones is the phosducin-like proteins (PhLPs) (Willardson and Howlett, 2007). It is known 
that they build ternary complexes with TRiC and the substrate. The exact mechanism by which 
they modify and assist the TRiC-dependent folding reactions is still unclear. PhLP1 is essential 
for the folding of the Gβ subunit of trimeric G-proteins (Lukov et al., 2006). PhLP3 has been 
reported to modulate the TRiC-dependent folding of actin and tubulin (Stirling et al., 2006). 
 
 
2.5 Chaperonin-Substrate Interaction 
The fate of chaperonin substrates during the interaction with the chaperonin has been 
investigated in great detail, especially for the bacterial GroEL/ES system. Substrates bind to 
hydrophobic residues in the apical domain of GroEL (Fenton et al., 1994). Binding of ATP to the 
equatorial domain of GroEL induces conformational changes that facilitate binding of GroES to 
the apical domain (Sigler et al., 1998). This in turn leads to release of the substrate from its 
GroEL binding sites and to encapsulation within the closed chaperonin cis ring. ATP hydrolysis 
results in a decreased stability of the GroEL/ES complex and finally ATP binding to the trans 
ring initiates release of GroES, substrate and ADP (Rye et al., 1997). 
It has been discussed intensively whether the GroEL cavity would be essentially working as a so 
called “Anfinsen cage” (Saibil et al., 1993), i.e. by passively preventing aggregation of the 
substrate by encapsulation (Apetri and Horwich, 2008; Horwich et al., 2009), or whether GroEL 
would, in addition, actively change the folding landscapes of its substrates by confinement 
within the cavity, thereby preventing formation of extended conformations and thus accelerating 
the rate of folding (Baumketner et al., 2003; Brinker et al., 2001; Tang et al., 2006). Recently it 
has been shown that the acceleration in the rate of folding of the GroEL substrate DM-MBP by 
GroEL can be mimicked by introduction of disulfide bonds into DM-MBP, which reduces the 
conformational space of the protein during folding (Chakraborty et al., 2010). Thus, similar rate 
acceleration can be achieved by different conformational constraints, either by confinement 
inside GroEL/ES or by disulfide bonds, strongly suggesting that confinement of substrates plays 
a major role in the mechanism of rate acceleration by GroEL/ES. 
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The mechanism of folding of substrates by the eukaryotic chaperonin TRiC contains additional 
layers of complexity. In contrast to GroEL, TRiC is not homo-oligomeric. In fact, the octameric 
rings of TRiC contain eight different but paralogous subunits (Figure 8) with approximately 30% 
amino acid identity that have diverged very early in the evolution of eukaryotes (Archibald et al., 
2001; Kubota et al., 1995). The different subunits are described by the Greek letters α, β, γ, δ, ε, 
ζ, η and θ in mammalian TRiC and by the numbers 1-8 in yeast (Yebenes et al., 2011). 
Comparison of the mammalian orthologous subunits reveals a high degree of conservation with 
an amino acid identity of 95% between the orthologues. 60% identity remains even between 
mammalian and yeast orthologues (Kim et al., 1994), suggesting non-redundant functions of the 
individual subunits in the hetero-oligomeric TRiC complex. The identity of amino acids between 
the different subunits is not equally distributed. The equatorial ATPase domains are much more 
similar than the apical substrate binding domains (Kim et al., 1994). Divergence of the apical 
domains suggests a specialization of the different subunits in substrate binding. 
Figure 8: The subunit orientation of TRiC. a) PDB file of respective crystal structure ((3P9D, Dekker 
et al., 2011) has been modified using PyMOL. Each TRiC subunit is colored in an individual color. 
Note one of the two homotypic contacts across the equator (red subunit). b) Schematic representation 
of TRiC subunit orientation adapted from Leitner at al., 2012. Each subunit is colored in an 
individual color. The homotypic inter-ring contacts of subunits 2 and 6 are indicated by dashed lines. 
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 Binding of Substrates to Chaperonins 2.5.1
In group I chaperonins, substrate binding is mediated by a hydrophobic groove between helices 
H and I in the apical domain (Chen and Sigler, 1999). It has been hypothesized that substrate 
binding in group II chaperonins takes place at a structurally related region between the apical 
helices H10 and H11 (Pereira et al., 2010). Strikingly, substrate specificity of different subunits 
for the known TRiC substrate VHL tumor suppressor can be transferred from one subunit to the 
other by exchanging the substrate binding motif in helix H11 (Spiess et al., 2006). Subunit 
specific binding of substrates to TRiC has also been shown for the most prominent substrates 
actin and tubulin (Llorca et al., 2000; Llorca et al., 1999a). It is well conceivable that the subunit 
specific binding of substrates plays an important role in the folding mechanism of TRiC-
dependent substrates, especially considering the presumed sequential mode of cavity closure. 
Furthermore, it was shown by FRET measurements that binding of actin to TRiC opens the 
nucleotide binding cleft of actin substantially more than binding to GroEL (Villebeck et al., 
2007a). Notably, GroEL can neither support folding of actin nor of tubulin (Tian et al., 1995). 
 
 The Size of the Chaperonin Cavity 2.5.2
The exact size of the TRiC cavity remains to be determined. Even before the high resolution 
structures were released, it was clear from lower resolution cryo-EM data (Booth et al., 2008) 
that the overall TRiC architecture is very similar to that of the thermosome from T. acidophilum 
whose cavity size was shown to be approximately 130,000 Å
3
 (Ditzel et al., 1998). Indeed, the 
crystal structure of yeast TRiC in the closed state estimated the TRiC cavity volume to be 
approximately 145,000 Å
3
 (Dekker et al., 2011a). This is only around 80% of the volume of the 
cis GroEL cavity which has a size of 175,000 Å
3
 (Xu et al., 1997). However, a recent cryo-EM 
study captured an asymmetric state of TRiC induced by ADP and AlFx exhibiting an enlarged 
cis cavity (Cong et al., 2011), which is likely to represent a physiological intermediate of the 
folding cycle as suggested by the negative cooperativity between the two rings of TRiC (Kafri et 
al., 2001; Yifrach and Horovitz, 1995). The size of this enlarged cavity is approximately 180,000 
Å
3
 and thus theoretically large enough for encapsulation of proteins up to 70 kDa. Similarly, the 
GroEL cis cavity could accommodate substrate proteins of up to 70 kDa (Xu et al., 1997). 
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However, it has been shown by protease protection experiments that the actual upper size limit is 
approximately 60 kDa (Sakikawa et al., 1999). 
 
 
2.6 Chaperonin Interactomes 
 Comparison of Prokaryotic and Eukaryotic Proteomes 2.6.1
Sequencing of whole genomes and subsequent assignment of protein coding regions has enabled 
the comparison of protein sequences from different kingdoms of life. Interestingly, eukaryotic 
proteins are on average approximately 50% longer than prokaryotic proteins (Zhang, 2000). 
However, protein domains have comparable average sizes of 200-250 amino acids in both 
eukaryotes and prokaryotes. Instead, the increased size of eukaryotic proteins (Figure 9) is 
caused by an increased number of domains per polypeptide in eukaryotes compared to 
prokaryotes (Brocchieri and Karlin, 2005). The different average size distributions of pro- and 
eukaryotic proteins are also reflected in the different interactomes of the respective 
representative chaperonins, GroEL and TRiC. 
 
 TRiC Interactors 2.6.2
In 2008, two independent studies have addressed the interactome of the eukaryotic chaperonin 
TRiC (Dekker et al., 2008; Yam et al., 2008). Dekker et al. investigated the TRiC interactome in 
yeast by both proteomic and genetic methods. Physical TRiC interactors were found by pull-
downs of TRiC complexes carrying an affinity tag, followed by mass spectrometry. Genetic 
interactors were identified by a synthetic genetic array (SGA) (Tong et al., 2001). All viable 
yeast deletion mutants were combined with a temperature-sensitive TRiC mutant and the 
resulting double-mutants were analyzed for synthetic sickness/lethality. Notably, genetic TRiC 
interactors do not represent TRiC substrates but they are rather functionally overlapping with 
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TRiC substrates. The combination of the compromised function of a TRiC substrate with the 
deletion of a protein with overlapping function causes the synthetic defect (Dekker et al., 2008). 
 
 
When known co-chaperones are excluded, 150 physical TRiC interactors remain in the Dekker 
et al. study among them the well described TRiC substrates actin and tubulin (Figure 10). 79 of 
the interactions have been identified by Dekker et al. themselves in their mass spectrometry 
experiments. 47 interactors originate from various comprehensive yeast protein-protein 
interaction studies cited by Dekker et al. (Gavin et al., 2006; Graumann et al., 2004; Ho et al., 
2002; Krogan et al., 2006). The remaining 24 interactors were described by Dekker et al. in the 
supplement without a precise indication of source. 
Figure 9: Size distribution of a prokaryotic and a eukaryotic proteome. The respective protein lists 
have been downloaded from http://ecocyc.org/query.shtml for E. coli and from 
http://downloads.yeastgenome.org/curation/calculated_protein_info/ for S. cerevisiae. 
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An independent study conducted by Yam et al. identified TRiC interactors by expression of 
mouse cDNAs in an in vitro transcription/translation system – rabbit reticulocyte lysate (RRL) –  
followed by a pull-down using an antibody targeting the TRiC β subunit. The screen comprised 
2600 cDNA clones, 1500 of which were estimated to result in detectable translation products. A 
list of 166 TRiC interactors is provided in the supplement of Yam et al., consisting of both 
interactors identified by Yam et al. themselves and of interactors described in the literature 
(Figure 10). Unfortunately, the sources of the interactions are not indicated and the list does not 
differentiate between mammalian and yeast proteins. 
A one-to-one comparison of the TRiC interactomes of the two studies is not possible because 
interactors from different organisms are described. However, it is reasonable to assume that the 
TRiC-dependency for folding might be conserved for a given TRiC substrate from yeast to 
mammals. The list of 166 TRiC interactors provided by Yam et al. contains 127 proteins that are 
either yeast proteins or proteins for which a yeast homologue is known. Surprisingly, only 34 of 
these proteins were also described by Dekker et al. to be TRiC interactors. Moreover, 24 of these 
interactors described by both studies were actually cited from the literature and thus they do not 
Figure 10: Comparison of TRiC interactomes described by Yam et al., 2008 (166 interactors) and 
Dekker et al., 2008 (150 interactors as described above). 
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represent a real experimental overlap. Interestingly, among the remaining 10 proteins that were 
identified by both studies are actin and tubulin. Thus, it seems that the provided lists of TRiC 
interactors might on the one hand contain a substantial number of false positive interactors while 
on the other hand a number of authentic interactors might be missing. Despite the small overlap 
between the studies by Dekker et al. and Yam et al. on the TRiC interactome, the size 
distributions of the described TRiC interactors of both studies are remarkably similar 
(Figure 10), suggesting that the lists provide a good reflection of the size distribution of the 
authentic TRiC interactome regardless of their imperfection in detail. 
 
 GroEL Interactors 2.6.3
252 substrates of GroEL have been described in E. coli (Kerner et al., 2005), 22 (~9%) of which 
exceed 70 kDa (Figure 11). It is unclear how folding of these larger substrates is achieved. A 
cryo-EM study described an unusually expanded cavity of the single-ring mutant of GroEL 
encapsulating a 86 kDa protein (Chen et al., 2006). Another study suggested that folding of an 82 
kDa substrate occurred via interaction with the GroEL trans ring without encapsulation by 
GroES (Chaudhuri et al., 2001). However, the physiological relevance of each of these 
mechanisms is not comprehensively understood so far. 
 
 Comparison of Interactors of GroEL and TRiC 2.6.4
Strikingly, the interactomes of the group I chaperonin GroEL and the group II chaperonin TRiC 
differ substantially with respect to their molecular weight distribution (Figure 11). Only 9% of 
the described GroEL interactors exceed the predicted upper size limit of the cis cavity of 70 kDa, 
essentially reflecting the size distribution of the E. coli proteome (http://ecocyc.org/query.shtml) 
with 7% of proteins larger than 70 kDa (Figure 9). Eukaryotic proteins have a higher average 
molecular weight than prokaryotic proteins (Brocchieri and Karlin, 2005; Netzer and Hartl, 
1998; Zhang, 2000) (Figure 9). In fact, one quarter of all proteins from the baker's yeast S. 
cerevisiae are larger than 70 kDa, as estimated from genomic data 
(http://downloads.yeastgenome.org/curation/calculated_protein_info/). The relative amount of 
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large TRiC substrates even exceeds this number; almost 40% of the described TRiC interactors 
are larger than 70 kDa, indicating that especially larger proteins need the assistance of TRiC for 
proper folding (Figures 10 and 11).  
 
 
 
2.7 Aim of the Study 
The mechanism by which chaperonins can assist the folding of proteins that are too large for 
encapsulation inside the central cavity is still unclear. It has been hypothesized that folding of 
large multi-domain substrates by TRiC might occur by partial encapsulation of the proteins 
(Spiess et al., 2004). This idea is especially interesting from an evolutionary perspective 
considering the sequential iris-like mechanism of lid closure (Pereira et al., 2010) that is found in 
group II chaperonins but not in group I chaperonins. It is tempting to speculate that this 
mechanism might have evolved to facilitate partial encapsulation of large multi-domain proteins, 
Figure 11: Size distributions of interactomes of GroEL and TRiC. 252 GroEL interactors as described 
by Kerner et al., 2005. 150 TRiC interactors from Dekker et al., 2008 modified as described above. 
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which is not straightforward if a GroES-like co-chaperone is required for closing the cavity. 
However, it has never been investigated whether partial encapsulation of large substrates in 
TRiC occurs, and if so, whether it leads to productive folding. 
The present work addressed these questions experimentally, using different fusion proteins of the 
well-described TRiC substrate actin with GFP and BFP as a model for large multi-domain 
proteins containing a TRiC-dependent domain. Actin folding was measured by two independent 
methods, its ability to bind to DNase I as well as the occurrence of a protease-resistant actin core 
in limited proteolysis experiments. Furthermore, the encapsulation of the actin fusion proteins or 
parts thereof inside the TRiC cavity was demonstrated by protection against proteolysis induced 
by closure of the chaperonin cage. In order to expand the study to a more physiological setting, 
various described TRiC interactors of large size were tested experimentally for interaction with 
TRiC and two strong interactors were tested for partial encapsulation.  
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3. Results 
3.1 TRiC-dependent Folding of Actin Fusion Proteins 
The cytoskeletal protein actin is well-suited to be used as a model TRiC substrate because it is 
strictly dependent on TRiC to reach its native state. It has been shown both in vitro (Gao et al., 
1992; Stemp et al., 2005) and in vivo (Chen et al., 1994; Vinh and Drubin, 1994) that TRiC 
function is required for proper folding of actin. It has been suggested that the interaction with 
TRiC is required to overcome a high energy barrier in the folding landscape of actin that occurs 
on the way towards a conformation that is able to bind nucleotide (Altschuler and Willison, 
2008). The folding of actin can be monitored by its ability to bind to DNase I (Lazarides and 
Lindberg, 1974; Mannherz et al., 1980). Actin and DNase I form a 1:1 complex via an 
interaction of a loop in sub-domain 2 of actin (Kabsch et al., 1990). Importantly, the interaction 
of actin with TRiC is sufficient for actin folding in contrast to folding of tubulin, which requires 
additional chaperones (Lewis et al., 1997). 
The actin sequence is highly conserved among eukaryotic species (Korn, 1982). In contrast, actin 
has diverged from its prokaryotic homolog MreB so far (van den Ent et al., 2001) that the 
structural relationship between both proteins was not apparent with pairwise sequence alignment 
(Erickson, 2007). Instead, a combination of sequence and structural alignments of actin, 
hexokinase and Hsc70, which all share the “actin fold” (Kabsch and Holmes, 1995), has led to 
the discovery of homologous bacterial proteins (Bork et al., 1992). Thus, the evolution of actin 
involved very rapid divergence from its prokaryotic homologs at the origin of eukaryotes 
followed by virtual constancy throughout eukaryotic evolution (Doolittle, 1995). The same 
phenomenon is found for tubulin, the other major cytoskeletal protein in eukaryotes (Doolittle, 
1995). Strikingly, the evolution of the TRiC substrates actin and tubulin resembles the evolution 
of the different TRiC subunits that have diverged rapidly after gene duplications at the origin of 
eukaryotes (Archibald et al., 2001) and have been much more conserved during the following 
eukaryotic evolution. 
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 Actin Fusion Proteins as Model for Multi-Domain TRiC Substrates 3.1.1
For my studies, I have used yeast actin (Act1p) which has 375 amino acids and is 88% identical 
to rabbit cytoplasmic β-actin. It has a molecular weight of approximately 42 kDa and is thus too 
small to serve as a model for proteins that are exceeding the TRiC cavity, which can 
accommodate proteins of 50-60 kDa (Dekker et al., 2011a; Ditzel et al., 1998) or even up to 
70 kDa (Cong et al., 2011). Therefore, I used fusion proteins, in which actin was connected with 
GFP alone or with BFP and GFP in different combinations (Figure 12) by flexible alanine-rich 
linkers. These linkers have all been derived from the 16 amino acid linker L16 
(TSGSAASAAGAGEAAA) that has been described in an earlier publication from our group 
(Chang et al., 2005). Most of the constructs I used for the initial DNase I binding experiments 
had been cloned by Markus Stemp, a former PhD student in the lab. I have cloned the BGA 
construct. 
 
 
 
Figure 12: Schematic representation of different actin fusion constructs. The calculated molecular 
weight of the respective constructs is indicated on top. The TEV-cleavage site in the linker between 
BFP and actin in BTAG is shown schematically. 
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 Actin Folding Estimated by DNase I Binding Experiments 3.1.2
The different actin fusion proteins were expressed in a coupled transcription/translation system 
from Promega, which is based on rabbit reticulocyte lysate (RRL), using plasmid DNA 
containing the respective genes as well as a T7 promoter. The proteins were labeled by L-[
35
S]-
Methionine incorporation and detected by autoradiography after SDS-PAGE. All proteins were 
soluble after expression in RRL. The DNase I binding experiment was designed in a way that 
resulted in a ten times higher concentration of the “Eluate” sample compared to the “Input” 
sample in order to enable the detection of weak binding to DNase I. Consequently, “Eluate” 
bands can have a higher intensity than “Input” bands (Figure 13a). Bands of equal intensity 
correspond to 10% binding to DNase I. 
 
To perform the pull-down assays, commercial DNase I was immobilized on CNBr-activated 
Sepharose. Actin alone served as a positive control for binding to DNase I. On average of 88% 
of the actin produced in RRL was pulled down from the lysate by the DNase I Sepharose beads 
Figure 13: Binding of fusion proteins to DNase I. a) Representative autoradiographs after SDS-PAGE, 
showing the amount of DNase I bound protein in comparison with one tenth of the input material. b) 
Quantification of the respective bands using the AIDA software (raytest). Error bars indicate the 
standard deviation of N≥3 independent experiments. 
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(Figure 13). BFP-GFP (BG) served as a negative control to monitor unspecific binding to the 
beads, which was determined to be 1% of the total synthesized protein on average (Figure 13). 
Thus, the DNase I binding assay exhibits a high range between specific and background binding, 
making it an appropriate tool for determination of actin folding. 
The amount of DNase I bound GA (36%) and AG (19%) in comparison to the BG background 
(1%) clearly indicates that a substantial fraction of actin in both fusion proteins reached the 
native DNase I binding competent conformation (Figure 13). However, DNase I binding was less 
efficient than for actin alone, indicating that the presence of GFP interferes with folding of actin. 
Apparently, the incompletely folded actin did not give rise to aggregates, as no insoluble protein 
was observed. The DNase I binding assay was always performed after 90 minutes of translation 
in RRL and the kinetics of occurrence of DNase I binding competent actin were not investigated. 
Therefore, it is possible that the rate of actin folding was decreased by the fusion with GFP and 
that more folded actin would have been produced after a longer period of incubation. There 
might be a change in the cycling rate of TRiC induced by the presence of a large substrate, 
leading to a slower turnover of the TRiC-GA and TRiC-AG complexes compared to the TRiC-
actin complex. More likely, the efficiency of the actin folding reaction was reduced for the 
fusion protein due to interference between the actin moiety and the fused GFP/BFP domain. 
Interestingly, the fraction of DNase I bound GA is almost twice as high as the fraction of 
DNase I bound AG (Figure 13). This is surprising because the N- and the C-terminus of actin are 
located in close proximity in sub-domain 1 (Kabsch et al., 1990) and thus GFP is expected to be 
in a similar position relative to actin in both GA and AG. However, both proteins differ 
obviously in their topological arrangement and the spatial constraints that are imposed on actin 
during the process of folding. Indeed, it has been suggested that the correct re-positioning of the 
actin C-terminus into its final location in sub-domain 1 is a late and essential step in the folding 
process of actin (Lee et al., 2012; Neirynck et al., 2006). It is possible that the presence of GFP at 
the actin C-terminus is interfering with this re-positioning step, thus making folding of AG less 
efficient compared to folding of GA. 
Both actin-GFP and GFP-actin fusion proteins are incorporated into cellular F-actin structures 
(Ballestrem et al., 1998; Doyle and Botstein, 1996; Fischer et al., 1998; Heidemann et al., 1999; 
Verkhusha et al., 1999; Yoon et al., 2002), indicating correct actin folding. However, it is not 
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clear if the GFP-actin fusion proteins are really too large for complete encapsulation inside the 
TRiC cavity. Thus, I analyzed a construct, in which two fluorescent proteins were fused to actin, 
namely BFP to the actin N-terminus and GFP to the actin C-terminus. DNase I binding of this 
construct (BAG) was close to the background level (Figure 13). In order to determine whether 
this was due to reduced folding of actin or due to impairment of DNase I binding by sterical 
reasons in presence of two fluorescent proteins, we prepared a construct, in which the linker 
between BFP and actin contained a TEV-cleavage site enabling selective removal of the N-
terminal BFP. TEV-cleavage of this construct (BTAG) results essentially in production of AG. 
We tested DNase I binding of BTAG after cleavage with the TEV (tobacco etch virus) protease 
(Parks et al., 1994) under two different conditions. Before cleavage of BFP, translation was 
stopped with either apyrase (Komoszynski and Wojtczak, 1996) or cycloheximide (McKeehan 
and Hardesty, 1969). Cycloheximide is a specific inhibitor of translation and does not affect the 
function of TRiC or other chaperones in the lysate. DNase I binding of AG produced by TEV-
cleavage of BTAG after translation stop with cycloheximide was comparable to DNase I binding 
of the regular AG construct described before, probably because TRiC was still active after 
cleavage. In contrast, addition of apyrase stops all ATP-dependent processes in the lysate, 
including TRiC function. The fact that DNase I binding of AG produced after cleavage of BTAG 
in presence of apyrase is not markedly different from DNase I binding of uncleaved BTAG 
indicates that actin was misfolded in the full-length BTAG protein (Figure 13). Thus, TRiC is 
unable to fold actin sided by GFP domains at both ends. 
The impaired folding of actin in BAG does not necessarily mean that folding of such “middle- 
domains” by TRiC is impossible. Another explanation is that imposing constraints on both the 
N- and the C-terminus of actin is fatal for actin folding, especially considering the close 
proximity of both termini in the actin structure. To test this possibility, we prepared another large 
fusion protein, in which only one of the actin termini is attached to fluorescent proteins. We used 
GA as a starting point for this new construct because GA was folded more efficiently than AG. 
Fusion of BFP to the GA N-terminus resulted in the construct BGA (99 kDa). 10% of BGA 
bound to DNase I on average, demonstrating that TRiC can mediate the folding of actin in 
context with such a large protein, although with reduced efficiency. 
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 Actin Folding Estimated by Protease-Resistant Actin Fragment 3.1.3
To confirm the results obtained by DNase I binding experiments, I used a different method to 
quantify actin folding. This method is based on the fact that fragments produced by limited 
proteolysis of native actin and of partially unfolded actin differ substantially (Kuznetsova et al., 
1999). Digest of native actin with proteases of different specificity results in C-terminal protease-
resistant fragments of 33-35 kDa dependent on the respective protease (Mornet and Ue, 1984). In 
contrast digest of non-native actin with various proteases does not result in production of a 
comparably stable protease-resistant fragment (Kuznetsova et al., 1999). Thus, it is conceivable 
that the relative amount of the protease-resistant actin fragment occurring upon digest of the 
different actin fusion proteins can be used as an inherent measure for the folding efficiency of 
each construct. 
In order to find out whether the protease-resistant actin fragment was indeed a useful measure for 
actin folding, we quantified the intensity of the respective fragment from PK digest reactions of 
various actin fusion proteins and correlated it to the intensity of the corresponding full-length 
protein band (incubated without PK). Indeed, the estimation of the relative amount of properly 
folded actin based on the ratio of the intensities of the protease-resistant fragment and of full-
length actin correlates well with the estimation of actin folding based on DNase I binding 
experiments (Figures 13 and 14). Thus, it appears that the relative intensity of the protease-
resistant fragment is a good estimate for actin folding. The quantification of actin folding by the 
occurrence of the protease-resistant fragment is particularly advantageous for the actin fusion 
constructs because the GFP and/or BFP domains hinder DNase I binding sterically, resulting in 
an underestimation of folded actin. 
- 37 - 
 
 
Comparison of the estimated folding efficiencies based on either the protease-resistant fragment 
or on DNase I binding reveals that in case of most actin fusion proteins, actin folding might have 
been indeed underestimated by DNase I binding (Figures 13 and 14). However, there is hardly 
any protease-resistant fragment detected upon digest of BAG (Figure 14), indicating once more 
that actin is not folded in the context of this particular fusion protein, as already inferred from 
DNase I binding experiments (Figure 13). Thus, despite the slightly different estimations of actin 
Figure 14: Actin folding estimated from protease-resistant actin fragment of 35 kDa. a) Representative 
autoradiograph of SDS-PAGE, showing PK digest of indicated actin fusion proteins. The molecular 
weight marker indicates the molecular weight in kDa. Protease-resistant BFP/GFP and the 35 kDa 
actin fragment (35K) are indicated on the right. b) Estimation of actin folding by quantification of the 
relative intensity of the 35 kDa actin fragment, corrected for number of methionine residues. The error 
bars indicate the standard deviation of N=3 independent experiments. 
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folding by DNase I binding and by intensity of the protease-resistant fragment, the overall 
conclusions that were based on DNase I binding remain unchanged.  
 
 Depletion of TRiC from RRL 3.1.4
To formally demonstrate the TRiC dependence of actin folding (Chen et al., 1994; Gao et al., 
1992; Stemp et al., 2005; Vinh and Drubin, 1994), TRiC was depleted from RRL. Depletion was 
achieved by Markus Stemp using the high affinity TRiC interactor PhLP1 that was purified after 
overexpression in E. coli. Purified PhLP1 was coupled to Dynabeads® TALON™ via an N-
terminal 6xHis-tag and used for depletion of TRiC from RRL. Depletion of TRiC led to a strong 
decrease in DNase I binding of actin and the actin fusion proteins AG and GA translated in the 
TRiC-depleted RRL (Figure 15). Production of DNase I binding competent actin and GA was 
completely restored by addition of TRiC that was purified from bovine testes (Figure 15). 
Surprisingly, DNase I binding of AG was only partially restored. It seems possible that rabbit 
TRiC from RRL and purified bovine TRiC differ in their ability to fold the less efficiently 
folding AG construct. 
 
 
Figure 15: DNase I binding after depletion of TRiC from RRL. a) Representative Western Blot anti-
CCTα showing successful depletion of TRiC from RRL. b) Quantification of DNase I binding. The 
error bars indicate the standard deviation N=3 independent experiments. 
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3.2 Stalling of Actin Fusion Proteins on the Ribosome 
 Stalling of Actin-GFP on the Ribosome 3.2.1
It has been shown by photo-crosslinking experiments that TRiC interacts co-translationally with 
ribosome-bound nascent chains (Etchells et al., 2005; McCallum et al., 2000). In order to test 
whether actin can be co-translationally folded into a native DNase I binding competent 
conformation, we prepared a shortened AG construct lacking a stop codon by PCR (AG219). 
This construct is translated in RRL like the full-length AG construct until the ribosome reaches 
the 3' end of the truncated mRNA, corresponding to amino acid 219 of GFP (Figure 16a). 
Because of the missing stop codon, a stalled ribosome nascent chain complex (RNC) is 
generated. 
In SDS-PAGE, the stalled nascent chain migrates characteristically at a molecular weight that is 
approximately 20 kDa higher than that of the free polypeptide chain because of the attached 
peptidyl-tRNA (Figure 16b). This enables the quantification of the stalling efficiency by 
comparison between the intensities of stalled (+ tRNA) and released (- tRNA) chains. The 
stalling efficiency varied between 15% and 45% for AG219 in different experiments. DNase I 
binding can be quantified for the stalled nascent chain and the free polypeptide chain separately 
because of their different migration in SDS-PAGE. Interestingly, neither the stalled nor the 
released AG219 were binding to DNase I substantially more than the previously determined 
BFP-GFP background (Figure 16c). It is quite likely that actin folding is compromised by 
association with misfolded GFP folding intermediates, especially considering the β-barrel 
structure of GFP that is prone to misfolding while incomplete (Craggs, 2009; Richardson and 
Richardson, 2002). 
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 Stalling of Actin-Luciferase on the Ribosome 3.2.2
In order to generate actin stalling constructs that had a protein other than GFP fused to the actin 
C-terminus, we prepared an actin-luciferase construct. Using PCR we created three stalling 
constructs that differed in the length of the luciferase sequence (AL36, AL49 and AL61). The 
numbers indicate the number of luciferase amino acids that are included in the respective 
construct. The ribosomal exit tunnel has a length of approximately 100 Å and accommodates 
roughly 35 amino acids of the nascent chain, assuming a fully extended conformation (Lu and 
Deutsch, 2005). Thus, there are approximately 18, 31 or 43 amino acids in between actin and the 
Figure 16: DNase I binding of stalled actin-GFP. a) Schematic representation of the stalled actin-GFP 
construct, not drawn to scale. Approximately 575 amino acids are outside the ribosomal exit tunnel, 
assuming that 35 amino acids span the distance from the peptidyl transferase center (PTC) until the 
end of the exit tunnel. The actin segment is thought to be separated from the ribosome by 200 amino 
acids in a stalled complex. b) Representative autoradiographs after SDS-PAGE. AG219 ± tRNA can 
be differentiated by different migration in SDS-PAGE. c) Quantification of the respective bands. The 
error bars indicate the standard deviation of N≥3 independent experiments. 
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ribosome in AL36, AL49 and AL61 respectively, considering the 17 amino acid linker between 
actin and luciferase (Figure 17a). 
 
Figure 17: Stalling of actin-luciferase. a) Schematic representation of stalled actin-luciferase 
constructs, not drawn to scale. Calculation of amino acids outside the exit tunnel was done assuming 
that 35 amino acids span the distance from the PTC to the end of the exit tunnel. b) Representative 
autoradiographs after SDS-PAGE. c) Quantification of respective bands of N=2 independent 
experiments. The error bar indicates the standard deviation. 
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Folding of the free polypeptide chains is inversely dependent on the length of the luciferase 
fragment. The shorter the luciferase fragment, the more of the actin fusion protein is binding to 
DNase I (Figure 17). It is not implausible that the tendency of the incomplete luciferase chain to 
misfold is increasing with its length, which in turn might impair the folding of actin as observed 
for the truncated actin-GFP fusion protein. The DNase I binding ability of the ribosome-bound 
actin-luciferase chains is independent of the length of the luciferase fragment. Moreover, the 
values are only slightly increased compared to the background level (Figure 17). Thus, it is not 
possible to conclude that folding of ribosome-bound actin occurred.  
 
 Stalling of Actin with a Flexible Linker on the Ribosome 3.2.3
In order to exclude that actin folding was impaired by the adjacent luciferase fragment, a flexible 
linker of 97 amino acids consisting of GGGGS-repeats without a stop codon was attached to the 
actin C-terminus for stalling of translation (Figure 18a). The linker DNA sequence contained 
three unique motifs for binding of different primers to enable the creation of stalling actin 
constructs with different lengths of linkers by PCR (ActLink53, ActLink78 and ActLink97). 
Assuming that 35 amino acids span the ribosomal exit tunnel, actin is separated from the 
ribosome by flexible linkers of 18, 43 or 62 amino acids, respectively (Figure 18a). 
Interestingly, DNase I binding of the ribosome-bound nascent chains again was close to the 
background level, independent of the length of the linker (Figure 18), suggesting that actin was 
not folded co-translationally into a DNase I binding competent conformation in either of the 
constructs. Thus, folding of actin at the ribosome appears generally impaired, independent of the 
linker length and sequence (Figures 16, 17, 18). 
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Figure 18: DNase I binding of stalled ActLink constructs. a) Schematic representation of ActLink 
constructs, not drawn to scale. Amino acids between actin and the ribosome were calculated assuming 
that 35 amino acids span the distance between the PTC and the end of the exit tunnel. b) 
Autoradiographs after SDS-PAGE showing the respective constructs ± tRNA. c) Quantification of the 
respective bands of N=1 experiment. 
- 44 - 
 
In order to discern released translation product present before the DNase I binding step from 
material hydrolyzed during DNase I binding, separate DNase I binding reactions were performed 
for the free polypeptide and the ribosome-bound nascent chains. The two species were separated 
by ultra-centrifugation through a sucrose-cushion, resulting in sedimentation of ribosomes and 
ribosome-bound nascent chains (Figure 19). 
 
To properly assess background binding, a folding-deficient version of actin carrying the point 
mutation G150P (McCormack et al., 2001a) was used. Alternatively, the translation reaction was 
supplemented with 5 μM purified PhLP1, which is a high affinity interactor of TRiC that was 
shown to inhibit TRiC-dependent folding of actin (McLaughlin et al., 2002). The released 
polypeptide chains of both ActLink78 and ActLink97 bound to DNase I significantly more than 
the two background controls (Figure 20). In contrast, the ribosome-bound nascent chains of both 
constructs did not differ in DNase I binding from the background controls (Figure 20), 
suggesting once more that the stalled actin chains were not properly folded. It thus appears that 
the close environment of the ribosome hinders the ability of TRiC to mediate actin folding. 
Figure 19: Separation of stalled from released ActLink78 by centrifugation through a sucrose cushion. 
Released ActLink78 is found in the supernatant. The ribosome-bound stalled nascent chains are 
enriched in the pellet fraction. The molecular weight in kDa is indicated. 
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Figure 20: DNase I binding of ActLink78 and ActLink97. Prior to DNase I binding, stalled (+tRNA) 
nascent chains were separated from released chains (-tRNA) by centrifugation through a sucrose 
cushion. a), c) Representative autoradiographs after SDS-PAGE. b), d) Quantification of the 
respective bands of N=2 independent experiments. Error bars indicate the standard deviation. a), b) 
show experiments with ActLink78, c), d) show experiments with ActLink97. 
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3.3 Proteinase K Protection Experiments 
Proteinase K (PK) is a rather unspecific protease from the fungus Tritirachium album (Ebeling et 
al., 1974). It cleaves flexible parts of proteins and is therefore often used to probe protein 
conformations. It has been shown that the TRiC subunits are sensitive to proteolytic digest at a 
flexible segment close to the helical protrusion at the tip of the apical domain (Szpikowska et al., 
1998). Such cleavage results in fragments of a molecular weight of around 30 kDa. Importantly, 
in the closed TRiC conformation the TRiC subunits are not sensitive to protease digest. 
Additionally, actin encapsulated in the TRiC cavity is also protected from protease (Meyer et al., 
2003). Thus, protease protection is an excellent tool to assess the extent to which a protein is 
encapsulated inside TRiC. Importantly, a stably closed TRiC complex can be generated by 
incubation with analogs of the transition state of ATP hydrolysis (Meyer et al., 2003). This is 
generally achieved by incubation of the protein of interest with ATP as well as aluminum and 
fluoride ions that build soluble aluminum fluoride complexes of different stoichiometries (AlFx) 
in solution (Chabre, 1990; Martin, 1988). 
 
 PK Protection of Purified Bovine TRiC by ATP and AlFx 3.3.1
To establish a protease protection assay, we first confirmed the results concerning the 
insensitivity of closed TRiC to protease digest. In line with the results of Meyer et al. TRiC from 
bovine testis is indeed protected from protease digest in presence of ATP and AlFx (Figure 21, 
lanes 7 and 8)). In presence of ADP and AlFx, which leads to closure of only one of the TRiC 
rings (Meyer et al., 2003), approximately half of the full-length TRiC subunits were protected 
(Figure 21, lanes 3 and 4). As expected, the effect is dependent on the presence of Mg
2+
 ions. 
Thus, no protection against PK digest is observed in presence of EDTA (Figure 21, lanes 11 and 
12). Furthermore, AlFx alone does not have any protective effect (Figure 21, lanes 9 and 10). 
Interestingly, the 30 kDa fragments of TRiC seem to be more sensitive to further digestion in 
absence of Mg-ATP or Mg-ADP (Figure 21, lanes 10 and 12 vs. lanes 2 and 6). Mg-ATP alone 
leads to a slight protection of the complete TRiC subunits, probably because a fraction of the 
TRiC molecules remains in the closed state during the digest due to the slow ATPase rate of 
TRiC in the absence of substrate (Gao et al., 1994; Melki and Cowan, 1994). In summary, the 
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experiments with purified TRiC suggest that stable closure of the TRiC cavity can be achieved 
by treatment with ATP and AlFx, thus enabling PK digest experiments to monitor the 
encapsulation of protein substrates. 
 
There are two principal strategies for obtaining TRiC-substrate complexes. First, purified 
unfolded substrate can be diluted from denaturant into a TRiC containing solution, followed by 
closure of the TRiC cavity with ATP and AlFx. Second, the substrate can be translated in RRL, 
which contains TRiC along with the cellular protein folding machinery, and the TRiC cavity is 
closed by addition of AlFx, providing a snapshot of encapsulated substrates at a given time. Most 
likely, binding of substrates to TRiC upon in vitro translation in RRL more closely resembles the 
in vivo situation of TRiC acting down-stream of ribosome-bound chaperones and the Hsp70 
system (Yam et al., 2008). Thus, PK protection experiments were performed on in vitro 
translation reactions. 
 
 
 
Figure 21: PK digest of purified bovine TRiC under different conditions. All reactions contained 
5 mM Mg
2+
. The figure shows a Coomassie stained gel after SDS-PAGE. The molecular weight 
standard given on the left side indicates the apparent molecular weight in kDa. Note the characteristic 
pattern of the different TRiC subunits around 60 kDa. 
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 PK Protection of Actin Fusion Proteins in RRL by ATP and AlFx 3.3.2
Treatments of actin with various proteases were reported to result in production of a common 
C-terminal protease-resistant fragment of approximately 35 kDa (Graceffa and Dominguez, 
2003; Higashi-Fujime et al., 1992; Jacobson and Rosenbusch, 1976; Schwyter et al., 1989). Such 
a fragment was also apparent in the present experiments with PK (Figures 14 and 22). 
Furthermore, a stable fragment of approximately 27 kDa was generated from actin fusion 
proteins but not from actin alone, suggesting that this fragment represents GFP and/or BFP 
respectively (Figure 22b-f).  
 
Figure 22: PK digest of actin fusion proteins in presence and absence of AlFx. The respective 
constructs have been transcribed and translated in RRL as described. Autoradiographs of gels after 
SDS-PAGE are shown. The molecular weight marker indicates the apparent molecular weight in kDa.  
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Additional bands were observed upon closure of the TRiC cavity induced by addition of AlFx to 
the RRL reaction (Figure 22). Presumably, these additional species were protected from PK 
digest by encapsulation inside the TRiC cavity. As expected, full-length actin was protected from 
PK digest upon treatment of RRL with AlFx, suggesting complete encapsulation of actin 
(Figure 22a). Interestingly, also full-length GA and AG were protected against PK digest in 
presence of ATP and AlFx (Figure 22b+c). In contrast, full-length BGA and BAG were not 
protected against PK digest (Figure 22d+e). Instead, a stable fragment of the size of GA was 
observed upon digest of BGA, suggesting that BGA was cleaved by PK within the flexible linker 
region between the BFP and the GFP moiety (Figure 22d). No protected actin-containing 
fragment was detected upon digest of BAG in presence of ATP and AlFx (Figure 22e), 
suggesting that BAG was not encapsulated inside TRiC. Digest of GA and BGA in presence of 
ATP and AlFx generates also fragments, which have approximately the molecular weight of 
actin (Figure 22b+d). Thus, the linker between actin and GFP was accessible to PK in a subset of 
TRiC-GA and TRiC-BGA complexes, indicating that TRiC-GA and TRiC-BGA complexes are 
heterogeneous with regard to their encapsulation inside the TRiC cavity. 
 
3.4 Analysis of TRiC-bound Proteins by Native PAGE 
Analysis of total RRL reactions was dominated by translation products that were not bound to 
TRiC and that gave rise to protease-resistant fragments independently of TRiC and AlFx 
(Figure 22). In order to concentrate on TRiC-dependent effects, TRiC-bound polypeptides were 
separated from the “free” proteins in solution prior to analysis. A gradient native PAGE ranging 
from 5-13% acrylamide in the separating gel was used to achieve this separation. To calibrate the 
gels, purified bovine TRiC was used with and without PK digest in presence and absence of 
AlFx. All TRiC complexes migrated in the upper quarter of the gel. Native PAGE was so 
sensitive that even the open and closed forms of TRiC were separated. The closed form was 
more compact and migrated faster than the open one (Figure 23). However, the AlFx-induced 
closed form of TRiC was not stable in absence of AlFx in the gel and thus several differently 
migrating species occurred during the gel run (Figure 23a). Including different amounts of AlFx 
into the gel mixture was used to control the mobility of the TRiC conformers: A high AlFx 
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concentration in the gel prevented opening of the AlFx-treated TRiC complexes but led in turn to 
closure of the not previously AlFx-treated complexes during the gel run (Figure 23b). Thus, a 
lower AlFx concentration was finally used for subsequent experiments as a trade-off between 
opening of AlFx-treated closed conformers and closure of untreated open conformers during the 
gel run (Figure 23c). 
 
 Native PAGE of Purified Bovine TRiC  3.4.1
Note that TRiC remained a hexadecamer upon treatment with PK in the absence of AlFx 
(Figure 23, lanes 2, 6, 10), even though the TRiC subunits were cleaved in the apical domain 
under these conditions (Figure 21, lane 6). The complexes containing the nicked subunits 
migrated slightly slower, suggesting a decreased compactness (Figure 23, lanes 2, 6, 10). 
 
 
 Native PAGE of RRL Reactions Translating Actin Fusion Proteins 3.4.2
When native PAGE gels of actin translation reactions were analyzed by autoradiography, a very 
similar band pattern was observed as for purified TRiC (Figures 23c and 24a). Notably, PK 
treatment in presence of AlFx did not alter the band pattern of TRiC-bound actin, suggesting that 
Figure 23: Native PAGE gels of purified bovine TRiC under different conditions. Sections of 
Coomassie stained native PAGE gels are shown. a) No AlFx in gel and in running buffers. b) 30 mM 
KF and 5 mM Al(NO3)3 in gel and running buffers. c) 6 mM KF and 1 mM Al(NO3)3 in gel and 
running buffers. 
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actin was encapsulated inside TRiC and thus protected from digest (Figure 24a). Similarly, also 
the closed complexes of TRiC with the two smaller actin fusion proteins GA and AG appeared 
unchanged upon incubation with PK in presence of AlFx (Figure 24b+c). Interestingly, the 
closed TRiC-GA and TRiC-AG complexes populated also slightly slower migrating 
conformations compared to TRiC-A (Figure 24a-c) and thus appeared as more heterogeneous 
and less compact than TRiC-A. 
 
The migration pattern of the TRiC-BGA and TRiC-BAG complexes differed drastically from the 
migration of the TRiC-A, TRiC-AG and TRiC-GA complexes in presence of AlFx 
(Figure 24d+e). No distinct band at the position of closed TRiC was visible. Instead, the material 
migrated as a diffuse band. In case of TRiC-BGA, a stack of bands was visible between open and 
closed TRiC, which was not seen in case of BAG (Figure 24d+e). This stack of bands and the 
diffuse material disappeared upon treatment with PK and the remaining protease-protected 
protein migrated at the position of closed TRiC (Figure 24d+e). 
Figure 24: Native PAGE of TRiC-substrate complexes. The respective constructs have been 
transcribed and translated in RRL, as described. Autoradiographs after native PAGE are shown.  
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Importantly, BG, which was used as a control throughout this study, did not bind to TRiC in any 
way comparable to the actin fusion proteins (Figure 24f) showing that the interaction of the actin 
fusion proteins with TRiC was indeed mediated by actin and not by BFP or GFP. 
 
 Elution of TRiC-bound Proteins from Native PAGE Gels 3.4.3
In order to determine the size of the protein species trapped on TRiC, the TRiC-bound proteins 
were eluted from the TRiC-containing region of the native gel with an SDS- and β-
mercaptoethanol-containing buffer. Similar results were obtained upon elution from native gels 
irrespective of the AlFx content in the gel. The additional protected fragments seen in the total 
lysate upon addition of AlFx (Figure 22) were also found upon elution of proteins from TRiC-
containing sections of native PAGE gels (Figure 25), indicating that their protection from PK 
digest was caused by encapsulation inside the TRiC cavity.  
In contrast, the bands ascribed to GFP and the stable 35 kDa actin fragment were found upon 
elution from native PAGE gels. Thus, occurrence of these fragments in SDS-PAGE of the total 
lysate (Figure 22) results from their inherent protease-resistance as stable segments of the 
natively folded final products. Interestingly, in case of the folding-compromised BAG construct 
there was no ATP and AlFx induced protection against PK digest, neither of the full-length 
protein nor of any fraction (Figure 25e). This finding suggests that an inability of encapsulation 
of the actin domain of BAG by TRiC might be causing the severe folding problems of this fusion 
construct. 
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Figure 25: SDS-PAGE of TRiC-bound proteins eluted from Native PAGE slices. A native gel has 
been Coomassie stained and the TRiC containing regions were cut separately lane by lane. Proteins 
were eluted from the gel slices and subsequently analyzed by SDS-PAGE. The molecular weight 
marker indicates the apparent molecular weight in kDa. 
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3.5 A Protease-Sensitive GFP-Mutant 
The AlFx-dependent protection of full-length GA and AG from PK digest suggests that these 
actin fusion proteins are completely encapsulated inside the TRiC cavity. However, it is formally 
not possible to conclude that a protein is completely encapsulated inside TRiC just because the 
full-length protein is protected from protease digest. In fact, a partially encapsulated protein 
whose protease-resistant parts protrude from the TRiC cavity would also be completely 
protected. GFP is resistant against PK digest (Figure 22) and thus it cannot be excluded that GA 
and AG are partially encapsulated inside TRiC with GFP protruding from the cavity. 
 
 ΔN-GFP-Actin is Completely Encapsulated inside the TRiC Cavity 3.5.1
To clarify this point, a protease-sensitive mutant of GFP was created by deletion of the N-
terminal residues 3-38, which essentially reflect two adjacent β-sheets of the eleven-stranded 
GFP β-barrel (Figure 26a). PK digest of ΔN-GFP-actin (ΔN-GA) resulted in only one protease-
resistant fragment, namely the stable 35 kDa actin fragment. A fragment of the size of ΔN-GFP 
was absent, indicating that ΔN-GFP is sensitive to digestion by PK. Nevertheless, full-length 
ΔN-GA was protected from PK by TRiC in presence of ATP and AlFx (Figure 26b), thus 
suggesting complete encapsulation. The band pattern of the ΔN-GA-TRiC complex in the 
native PAGE gel was very similar to the pattern observed for actin bound to TRiC (Figure 26c). 
Elution of TRiC-bound proteins from native gel slices, followed by SDS-PAGE of the eluted 
proteins (Figure 26d), revealed that the protected full-length ΔN-GA was indeed bound to TRiC, 
suggesting that its protection from PK was caused by encapsulation inside the TRiC cavity. The 
complete encapsulation of ΔN-GA does not necessarily imply that GA is also completely 
encapsulated, because the folded GFP β-barrel might behave differently from ΔN-GFP. 
- 55 - 
 
 
 
 Native PAGE Mobility Shift Assay 3.5.2
To analyze the encapsulation status of GA by a different experimental approach, the availability 
of the protein to an anti-GFP antibody upon closure of the TRiC cavity was tested. In fact, a 
mixture of two monoclonal anti-GFP antibodies was used. It has been described that binding of 
antibodies to protein complexes can be detected as a mobility shift in native PAGE (Swamy et 
al., 2007). The mobility of the open TRiC-substrate complex in absence of AlFx was shifted by 
anti-GFP in case of GA but not in case of A, indicating a specific binding to GFP (Figure 27a). 
The shift also occurred in case of ΔN-GA, indicating that the epitope of at least one of the 
antibodies was not localized within the N-terminal 38 amino acids of GFP. Interestingly, a 
fraction of the TRiC-GA complex was shifted by anti-GFP even after closure of the TRiC cavity 
Figure 26: PK digest of ΔN-GA. ΔN-GA was translated in RRL as described. a) Top: Schematic 
representation of ΔN-GA. Bottom: Crystal structure of GFP (1EMA) (Ormo et al., 1996). The deletion 
of the N-terminal two β-strands in ΔN-GFP is indicated by dark color (done with PyMOL). b) 
Autoradiograph after SDS-PAGE of total RRL. c) Autoradiograph after Native PAGE. d) 
Autoradiograph after SDS-PAGE of TRiC-bound proteins eluted from native gel. The molecular 
weight markers indicate the apparent molecular weight in kDa. 
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by ATP and AlFx (Figure 27b). Thus, GFP seems to be outside the TRiC cavity in a subset of 
complexes, even though full-length GA is protected from PK digest upon closure of the TRiC 
cavity. It appears that GFP is located at the cavity entrance in a way that blocks access of PK to 
the protease-sensitive linker between GFP and actin. In contrast to TRiC-GA, TRiC-ΔN-GA was 
not shifted when the TRiC cavity was closed (Figure 27b), thus confirming the total 
encapsulation of ΔN-GA. 
 
 
 DNase I Binding of ΔN-GFP-Actin Fusion Proteins 3.5.3
Interestingly, DNase I binding experiments indicated that actin folding in ΔN-GA is severely 
impaired (Figure 28). A possible explanation is that the folding incompetent ΔN-GFP interfered 
with actin folding. If folding of actin occurred fast and co-translationally, the folding reaction 
would not be disturbed by ΔN-GFP attached to the actin C-terminus. However, no substantial 
binding of Actin-ΔN-GFP (AΔN-G) to DNase I was observed (Figure 28), once again supporting 
Figure 27: Antibody-based mobility shift. a) Autoradiograph after native PAGE. The respective 
proteins have been made in RRL as described and incubated with 10 ng/µl anti-GFP prior to native 
PAGE. b) Autoradiograph after native PAGE. Only samples and gel on the right side were treated 
with AlFx. The shifted TRiC-GA complex migrated as a diffuse band in presence of AlFx and is 
indicated by an arrowhead. 
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the conclusion that folding of actin to the DNase I binding competent conformation is not 
completed co-translationally. 
 
In summary, the experiments with different fusion proteins containing the TRiC-dependent 
protein actin and the fluorescent proteins BFP and GFP in various combinations led to the 
following conclusions:  
1. TRiC can fold domains of multi-domain proteins that are in total too large for complete 
encapsulation (Figures 13 and 14).  
2. Folding of actin is unlikely to be completed co-translationally, as stalled actin fusion 
proteins do not bind to DNase I (Figures 16, 17, 18 and 20). 
3. TRiC is able to partially encapsulate large multi-domain proteins as shown by protease 
protection experiments (Figures 22, 24 and 25) and by an antibody-based mobility shift in 
native PAGE (Figure 27). 
 
 
 
Figure 28: DNase I binding of ΔN-GA and AΔN-G. AG and GA have been tested as positive controls 
in parallel. a) Representative autoradiographs after SDS-PAGE. b) Quantification of the respective 
bands of N=3 independent experiments. 
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3.6 Investigating Naturally Occurring Large TRiC Substrates 
 Testing Human Homologs of Known TRiC Interactors 3.6.1
In order to test whether the principles governing the folding of actin fusion proteins are also valid 
for large natural substrates of TRiC, several known large TRiC interactors were expressed in 
RRL. In 2008, two independent studies investigated the interactome of the eukaryotic chaperonin 
TRiC (Dekker et al., 2008; Yam et al., 2008). Since a comprehensive human cDNA library was 
available in our institute, human homologs of the described interactors were tested. In case of the 
yeast interactors described by Dekker et al., the most suitable homologs were identified using 
BLAST. However, in some cases only a low degree of homology was identified. Three of the 
human genes (GANAB, MUC17 and DYNC1H1) were available only as 5'-deleted constructs, 
thus giving rise to N-terminally truncated proteins (Table 1). The smallest protein tested was 83 
kDa in size and the largest had a molecular weight of 273 kDa (Table 1). 
We expressed the constructs in RRL and probed the interaction with TRiC by native PAGE 
(Figure 29). Note that the band intensities are not absolutely comparable. For comparison the 
constructs with known TRiC-binding ability (BG, GA and BGA) are shown (Figure 29a). Four 
constructs (THNSL1, ATP6V0A1, NUP153, MUC17) were only poorly expressed in RRL 
(Figure 29). The product of the THNSL1 gene nevertheless bound strongly to TRiC. The 
translation products of most constructs were binding less well to TRiC than the model actin 
fusion proteins GA and BGA. The translation products of two constructs, EFTUD2 and COPB2, 
bound to TRiC with similar efficiencies as the actin fusion proteins tested before (Figure 29). 
Thus, we decided to focus on these two candidates. 
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TRiC Interactor Described by Human Gene Construct MW (kDa) 
eEF2 Yam et al. EEF2 Full-Length 95 
Teashirt 3 Yam et al. TSHZ3 Full-Length 99 
SnRNP116 Yam et al. EFTUD2 Full-Length 109 
Met18 Yam et al. MMS19 Full-Length 113 
Uba1 Yam et al. UBA1 Full-Length 118 
LeuRS Yam et al. LARS Full-Length 135 
Skiv2l Yam et al. SKIV2L Full-Length 138 
Kip3 Yam et al. KIF13A Full-Length 199 
Myosin Yam et al. MYH1 Full-Length 223 
Fas2 Yam et al. FASN Full-Length 273 
Aro1 Dekker et al. THNSL1 Full-Length 83 
Ubp3 Dekker et al. USP10 Full-Length 87 
Stv1 Dekker et al. ATP6V0A1 Full-Length 96 
Sec27 Dekker et al. COPB2 Full-Length 102 
Rot2 Dekker et al. GANAB ΔN (1-97) 96 
Swi3 Dekker et al. SMARCC2 Full-Length 133 
Nup1 Dekker et al. NUP153 Full-Length 154 
Sla1 Dekker et al. MUC17 ΔN (1-3270) 128 
Dyn1 Dekker et al. DYNC1H1 ΔN (1-3658) 112 
 
 hSnu114 – A Strong TRiC Interactor 3.6.2
The human gene EFTUD2 encodes a 972 amino acid protein with a molecular weight of 109 kDa 
(Figure 30) that is homologous to the essential yeast protein Snu114 (Fabrizio et al., 1997). The 
two proteins have 33% sequence identity and the human one is also called hSnu114 (Frazer et 
al., 2008). We will refer to this protein as hSnu114, although alternative names are used in the 
Table 1: Putative TRiC substrates tested for binding to TRiC upon expression in RRL. The first 
column provides the name of the described TRiC interactor as given in the respective publication. The 
third column provides the name of the human gene corresponding to the described interactor.  
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literature, such as SnRNP116 (Yam et al., 2008) or U5-116kD (Fabrizio et al., 1997) because of 
its apparent molecular weight and its being a part of the U5 snRNP (Bach et al., 1989). Snu114 is 
a GTPase and it regulates the activity of the ATP-dependent helicase Brr2, dependent on whether 
GTP or GDP is bound (Small et al., 2006). In turn, active Brr2 unwinds the U4/U6 snRNAs 
(Maeder et al., 2009), which is required for activation of the spliceosome (Wahl et al., 2009). 
 
The 3D-structure of Snu114 is not known. However, sequence homology (Fabrizio et al., 1997) 
suggests that the structure of Snu114 is similar to that of eukaryotic elongation factor 2 (eEF2) 
(Jorgensen et al., 2006), for which several crystal structures are available (Jorgensen et al., 2005; 
Figure 29: Binding of putative natural substrates to TRiC. The respective constructs were transcribed 
and translated in RRL and analyzed by SDS-PAGE (Total Full-Length Substrate) and native PAGE 
(TRiC-Substrate Complex). The gel sections entitled “Total Full-Length Substrates” show 
autoradiographs of gels after SDS-PAGE. Only a section of the gels corresponding to the respective 
full-length constructs is shown. Truncated translation products were observed as well for some of the 
constructs. The gel sections entitled “TRiC-Substrate Complex” represent autoradiographs of gels 
after native PAGE. The constructs in a), b) and c) are arranged according to the expected molecular 
weights of the respective full-length proteins from low (top) to high (bottom). a) Fusion proteins of 
fluorescent proteins and/or actin are shown as negative (BG) and positive (GA and BGA) controls for 
binding to TRiC. b) Human homologs of putative TRiC substrates described by Yam et al., 2008. c) 
Human homologs of TRiC substrates described by Dekker et al., 2008. 
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Jorgensen et al., 2003; Jorgensen et al., 2004; Soe et al., 2007). Elongation factor 2 is composed 
of six domains in total: G, G', II, III, IV and V. Domain G' is inserted into domain G (or I) and 
domain V is inserted into domain IV (Jorgensen et al., 2003). The N-terminal part of the protein, 
consisting of domains G, G' and II contains the GTP-binding module and resembles the 
prokaryotic EF-Tu and the eukaryotic EF1α factors that deliver aminoacyl-tRNAs to the 
ribosome, while the C-terminal part, consisting of domains III, IV and V, is shaped similar to an 
aminoacyl-tRNA, providing an excellent example of molecular mimicry (Nissen et al., 1995). In 
addition to the described domains of eEF2, hSnu114 contains 110 mainly acidic amino acids at 
the N-terminus (Figure 30). 
 
 
 
 
 
Figure 30: Structural models of the putative TRiC substrates hSnu114 (top) and β'-COP (bottom). 
White boxes in a) and c) indicate parts of the respective proteins not included in the crystal structures. 
a) Putative domain structure of hSnu114 based on homology to eEF2, whose structure is shown in b) 
based on the PDB file 1NOV (Jorgensen et al., 2003). c) Domain structure of human β'-COP based on 
the crystal structure of yeast β'-COP shown in d) (3MKQ, Lee and Goldberg, 2010). 
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 β'-COP – A WD40 Domain Containing Interactor of TRiC 3.6.3
The human gene COPB2 encodes a 906 amino acid protein with a molecular weight of 102 kDa 
that is homologous to the yeast protein Sec27 (Duden et al., 1994) and that is commonly called 
β'-COP (Figure 30). The protein is well conserved from yeast to humans, the sequences being 
47% identical. β'-COP is involved in retrograde vesicular transport from the Golgi apparatus to 
the ER (Duden, 2003). It recognizes its cargo by specifically binding to di-lysine motifs via its 
N-terminal WD40 domain (Eugster et al., 2004). The crystal structure of the N-terminal 812 
amino acids of yeast β'-COP has recently been solved (Figure 30d) in complex with the α-
solenoid domain of α-COP (Lee and Goldberg, 2010). β'-COP contains two N-terminal WD40-
repeat domains that form seven-bladed β-propellers (Smith et al., 1999), a domain that is often 
found in TRiC substrates (Valpuesta et al., 2002). However, it is not known whether the folding 
of β'-COP is actually dependent on TRiC. 
 
 Expressing N- and C-terminal hSnu114 and β'-COP Parts separately 3.6.4
In order to identify TRiC-dependent domains in β'-COP and hSnu114, different constructs 
comprising either N- or C-terminal parts of the respective proteins were generated. Specifically, 
for hSnu114 an N-terminal construct (hSnu114-N, amino acids 1-580) comprising domains G, G' 
and II and a C-terminal construct (hSnu114-C, amino acids 581-972) comprising domains III, IV 
and V were produced (Figure 30a). Similarly, for β'-COP an N-terminal construct (β'-COP-N, 
amino acids 1-283) was designed to contain only the N-terminal propeller and a C-terminal 
construct (β'-COP-C, amino acids 284-906) comprising the rest of the protein. Unfortunately, the 
crystal structure of β'-COP, which was published after design of β'-COP-N and β'-COP-C, 
revealed that β'-COP-N misses the two β-strands 7B and 7C (Lee and Goldberg, 2010) of the N-
terminal propeller blade. This potentially causes a severe folding defect. 
We tested the interaction of the N- and C-terminal constructs of hSnu114 and β'-COP with TRiC 
by native PAGE. As judged from the TRiC-containing gel sections, the hSnu114-N construct 
barely interacted with TRiC, in contrast to the hSnu114-C construct that bound TRiC as strongly 
as the full-length protein (Figure 31a), suggesting that the TRiC-binding site of hSnu114 is 
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located in the C-terminal part. In the case of β'-COP, the N-terminal β'-COP construct (β'-COP-
N) interacted more strongly with TRiC than β'-COP-C (Figure 31b). 
 
 
 Partial Encapsulation of hSnu114 3.6.5
Next, we analyzed whether partial encapsulation of the two natural TRiC interactors occurred. 
PK protection experiments were performed as described for the actin fusion proteins. PK 
treatment of the total translation reactions resulted in a number of protease-resistant fragments 
for both constructs. Three fragments of major intensity appeared upon digest of hSnu114 and had 
apparent molecular weights of approximately 50 kDa, 55 kDa and 95 kDa (Figure 32a). For β'-
COP, two major fragments of approximately 30 kDa and 70 kDa were observed (Figure 32a). 
These fragments might represent the N-terminal WD40-repeat domain and the remaining C-
terminal part of the protein (Figure 30). Addition of AlFx had little effect on the fragmentation in 
total translation reactions (Figure 32a). 
Probably, the autoradiographs (Figure 32) are dominated by protease-resistant fragments 
generated from proteins that are not bound to TRiC. Therefore, the TRiC-bound proteins were 
eluted from TRiC-containing slices of the native gel and separated by SDS-PAGE. Indeed, ATP 
and AlFx dependent protection of fragments was detected in the TRiC-bound fractions. These 
Figure 31: Binding of N- and C-terminal constructs of hSnu114 (a) and β'-COP (b) to TRiC. The 
respective constructs were transcribed and translated in RRL and the translation reactions were 
analyzed by SDS-PAGE and native PAGE as in Figure 29. 
- 64 - 
 
protected fragments were smaller than 60 kDa for both natural substrates. In case of β'-COP, 
mainly incomplete translation products were protected. These fragments were so abundant that 
they might have obscured any protected fragments originating form full-length β'-COP. In 
contrast, closure of the TRiC cavity resulted in protection of at least five different fragments of 
hSnu114, having apparent molecular weights between approximately 15 kDa and 45 kDa (Figure 
32b). It was not clear if the protected fragments originated from partial encapsulation of full-
length hSnu114 or partial encapsulation of truncated fragments of hSnu114. However, the band 
intensities suggested that the fragments had to be derived at least in part from full-length 
hSnu114. 
 
Figure 32: PK digest of hSnu114 and β'-COP in presence and absence of AlFx. The respective 
constructs were transcribed and translated in RRL. a) Samples of the total lysate after SDS-PAGE. 
b) TRiC-bound proteins after elution from native gels and subsequent SDS-PAGE. The molecular 
weight markers indicate the apparent molecular weight in kDa. Fragments occurring after digest are 
indicated by arrows and the approximate apparent molecular weight. 
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 The C-terminal Part of hSnu114 Binds Strongly to TRiC 3.6.6
The experiments above did not define which part of hSnu114 was encapsulated inside the TRiC 
cavity. To determine the identity of the encapsulated fragments, the N- and C-terminal constructs 
of hSnu114 (hSnu114-N (amino acids 1-580) and hSnu114-C (amino acids 581-972)) were 
expressed and analyzed for AlFx-induced protease protection.  
 
Figure 33: PK digest of hSnu114-N and hSnu114-C in presence and absence of AlFx. The respective 
constructs were transcribed and translated in RRL. a), b) Samples of the total lysate after SDS-PAGE. 
c), d) TRiC-bound proteins after elution from native gels and subsequent SDS-PAGE. The molecular 
weight markers indicate the apparent molecular weight in kDa. Smaller fragments after digest are 
indicated by arrows and the approximate apparent molecular weight. 
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PK treatment of hSnu114-N resulted in the formation of two major fragments of approximately 
45 kDa and 55 kDa, regardless of whether AlFx was present or not (Figure 33a). Similar 
protease-resistant fragments were observed upon digest of full-length hSnu114 (Figure 32a). 
Previous experiments showed that hSnu114-N binds only very weakly to TRiC (Figure 31a). 
Indeed, elution of TRiC-containing sections of a native gel resulted in barely detectable amounts 
of hSnu114-N (Figure 33c), indicating that the N-terminus of hSnu114 is most likely not the 
TRiC-dependent part of the protein. In contrast, substantial amounts of TRiC-bound hSnu114-C 
were eluted from the TRiC-containing band of a native gel. Furthermore, TRiC-bound hSnu114-
C was protected from PK digest in presence of ATP and AlFx (Figure 33d), suggesting complete 
encapsulation inside the TRiC cavity. Surprisingly, the observed TRiC-bound fragments of full-
length hSnu114 that were protected against PK digest in presence of ATP and AlFx (Figure 32b) 
were not reproduced with hSnu114-C. Thus, the PK protection experiments indicate that 
hSnu114-C contains the high affinity TRiC-binding site of hSnu114 but that hSnu114-C and full-
length hSnu114 nevertheless differ in the way they are encapsulated by TRiC. The 45 kDa 
hSnu114-C is completely encapsulated inside TRiC, while full-length hSnu114 gives rise to 
several smaller fragments between 15 kDa and 45 kDa (Figure 32b). 
 
Partial encapsulation of full-length hSnu114 became also apparent in the migration pattern of the 
TRiC-hSnu114 complex during native PAGE. In presence of ATP and AlFx, the TRiC-hSnu114 
complex migrated more slowly than closed TRiC (asterisk in Figure 34). Upon PK digest, a 
mobility similar to closed TRiC was observed (Figure 34a), probably because protruding parts of 
Figure 34: Native PAGE of different hSnu114 constructs showing TRiC-substrate complexes. The 
respective constructs were transcribed and translated in RRL. Autoradiographs of TRiC-containing 
sections of native gels are shown. 
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hSnu114, which caused the aberrant migration properties, were cleaved by PK. A similar 
phenomenon was observed with the TRiC-BGA complex, which also migrated more slowly than 
TRiC alone in presence of ATP and AlFx and which was accelerated after cleavage of the BFP 
moiety by PK, indicating partial encapsulation of BGA (Figure 24). The TRiC-hSnu114-C 
complex exhibited the normal migration pattern (Figure 34c) in line with full encapsulation 
inside the TRiC cavity as supported by the protease protection experiments (Figure 33b+d). 
 
 Protected Fragments Originate from the C-terminus of hSnu114 3.6.7
Experiments with the N- and C-terminal parts of hSnu114 had suggested that the interaction with 
TRiC was mediated through the hSnu114 C-terminus (Figures 31, 33, 34). In order to determine 
the origin of the observed protease-protected fragments, either the N- or the C-terminus of 
hSnu114 was combined with an HA-tag, resulting in constructs HA-hSnu114 and hSnu114-HA, 
respectively, for detection by Western blot. Additionally, the constructs contained a FLAG-tag at 
the opposite chain terminus. However, the antibody directed against the FLAG epitope was not 
sensitive enough to detect the limited amounts of protein that were produced by in vitro 
translation in RRL. 
PK treatment resulted in elimination of the HA-epitope of HA-hSnu114, both in the presence and 
absence of AlFx (Figure 35a). In contrast, a pattern of protected fragments similar to the original 
fragments of radiolabeled hSnu114 (Figure 32b) was detected by the anti-HA antibody in 
hSnu114-HA (Figure 35b), indicating that the observed fragments originated from the C-
terminus of hSnu114. The 45 kDa fragment observed with the radiolabeled protein, was not 
detected on the anti-HA western blot, suggesting that encapsulation leading to this fragment 
excluded the HA-tag. 
The same fragments observed in total RRL (Figure 35b) were also present in the TRiC-bound 
fraction (Figure 35d), indicating that protection of the HA-epitope was indeed caused by 
encapsulation of the C-terminus of hSnu114 inside the TRiC cavity.  
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In order to relate the protease protected fragments to the hSnu114 domain structure, a homology 
model based on the structure of eEF2 (Jorgensen et al., 2003) was used. Note that domain V 
(purple) is inserted into domain IV (red) (Figure 30a).  
 
Figure 35: Detection of hSnu114 N- and C-terminus by Western blot. Transferred proteins were 
detected using an anti-HA antibody. The molecular weight markers indicate the apparent molecular 
weight in kDa. Protected fragments are indicated by arrows and the respective approximate apparent 
molecular weight in kDa. a) and b) Western blot after SDS-PAGE of samples of total RRL lysate. c) 
Western blot after native PAGE. d) Western blot after SDS-PAGE of TRiC-bound proteins eluted 
from native gels. 
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The smallest observed fragment has a molecular weight of approximately 15 kDa and might 
correspond to domain V and the C-terminal part of domain IV (Figure 36b). The complete 
domains IV and V together are 315 amino acids in length and have an approximate molecular 
weight of 35 kDa (Figure 36c). This corresponds roughly to the largest observed C-terminal 
fragment. Interestingly, the two fragments with the highest intensity have apparent molecular 
weights of approximately 20 kDa and 27 kDa. Thus, they seem to originate from encapsulation 
Figure 36: Structural analysis of partial encapsulation of hSnu114. The crystal structure of yeast eEF2 
(1NOV, Jorgensen et al., 2003) was colored according to its domain structure using PyMOL. Domain 
G is shown in dark blue and domain G' in light blue. Domain II is shown in green, domain III in 
yellow, domain IV in red and domain V in purple. N- and C-termini are indicated when visible. The 
structures on the right represent a 90° rotated view. b) The C-terminal part of domain IV and 
additionally domain V were colored in dark grey to indicate parts of the corresponding hSnu114 
structure, which likely gives rise to the protected 15 kDa fragment (Figures 32 and 35). c) Domain IV 
and domain V were colored in dark grey to indicate parts of the corresponding hSnu114 structure, 
which might give rise to the protected 35 kDa fragment. 
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of the C-terminal part of domain IV plus domain V as well as parts of the N-terminal portion of 
domain IV. This is surprising, as it would be expected that all parts of the protein that are 
forming a single domain in the native protein should be encapsulated together to allow formation 
of the native structure during the time of encapsulation. 
Furthermore, the sizes of the protected fragments were unexpected. All fragments were smaller 
than 50 kDa and thus the encapsulated segment of hSnu114 was not simply determined by the 
maximum capacity of the TRiC cavity. Rather, it appears that more specific mechanisms govern 
the selectivity for certain parts to be encapsulated inside the TRiC cavity. The results for the N- 
and C-terminal parts of hSnu114 are interesting in this regard. While hSnu114-N was not 
binding to TRiC and was therefore also not protected from PK digest upon closure of the TRiC 
cavity, hSnu114-C, which has a molecular weight of approximately 45 kDa, was completely 
protected from PK digest, suggesting total encapsulation of hSnu114-C. Thus, the occurrence of 
smaller protected fragments from the full-length protein is dependent on the presence of the N-
terminal part of hSnu114. How this works mechanistically remains to be determined. 
It is especially intriguing in this context that so many fragments of different sizes have been 
protected from PK digest by encapsulation inside the TRiC cavity. Possibly, the different 
fragments reflect snapshots of hSnu114 at different stages of folding. Assuming that the N-
terminal domain folds independently into a stable structure, which is supported by stable 
fragments generated upon digest of hSnu114-N (Figure 33a), it is conceivable that folding of the 
C-terminal part of hSnu114 proceeds by stepwise addition of folding units onto a growing N-
terminal core. According to this interpretation, the larger protected fragments reflect earlier 
stages of folding, in which the C-terminal part of hSnu114 is largely unfolded and consequently 
encapsulated inside TRiC. In contrast, the smallest fragment provides a snapshot of the final step 
of folding, in which the very C-terminal part is finally folded and combined with the remaining 
parts of the protein to form the folded hSnu114. 
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In summary, the experiments with the natural TRiC interactor hSnu114 led to the following 
insights: 
1. The TRiC-hSnu114 interaction is most likely mediated by the C-terminal part of hSnu114 
as suggested by the fact that a construct comprising the N-terminal amino acids 1-580 is 
hardly interacting at all with TRiC, in contrast to a construct comprising the C-terminal 
amino acids 581-972. 
2. Consequently, TRiC encapsulates C-terminal fragments of hSnu114 upon closure of the 
cavity. The fragments have apparent molecular weights of approximately 15-45 kDa and 
are thus much smaller than the maximal capacity of TRiC. 
3. Not all fragments are matching with the domain boundaries of hSnu114 as predicted by 
its homology to eEF2, suggesting that partial encapsulation of domains might occur. 
4. The occurrence of multiple protected fragments suggests a stepwise folding mechanism 
of hSnu114, in which folding units are added sequentially onto a growing N-terminal 
core. 
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4. Discussion 
4.1 Partial Encapsulation of Multi-Domain Proteins 
The volume of the TRiC cavity was estimated to be large enough for complete encapsulation of 
substrates of 60-70 kDa (Cong et al., 2011; Dekker et al., 2011a). However, 30-50% of the 
known TRiC interactors exceed these size limits (Figure 10). Assuming that many of the large 
TRiC interactors represent authentic TRiC substrates, specific mechanisms must exist to enable 
folding of such large client proteins. Since productive folding requires protein encapsulation 
(Reissmann et al. 2007), the only logical mechanism to achieve the folding of large proteins is 
partial encapsulation. However, partial encapsulation of substrates inside TRiC has never been 
shown experimentally. 
The mechanism of folding by partial encapsulation is especially interesting considering that more 
than 70% of eukaryotic proteins are multi-domain proteins (Han et al., 2007; Jacob et al., 2007). 
Typical domain sizes range from 50-300 amino acids (Netzer and Hartl, 1998). Thus, a typical 
domain would easily fit inside the TRiC cavity and partial encapsulation might occur in a 
domain-wise manner, in which the rest of the protein would be located outside the closed cavity 
where it cannot interfere with the folding process (Figure 37). The experiments with actin fusion 
proteins presented in this study confirm the importance of domain-wise encapsulation. By 
encapsulating only the actin moiety of the fusion protein, as in the case of GFP-actin, it is 
ensured that folding of actin can occur undisturbed. However, replacement of the stably folded 
GFP domain by the misfolded ΔN-GFP in the fusion protein results in complete encapsulation 
(Figures 26 and 27) and consequently severely disturbs the folding of actin (Figure 28), probably 
because inappropriate contacts between actin and ΔN-GFP occur. 
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Therefore, it is expected that TRiC would preferentially encapsulate only the TRiC-dependent 
domain of a multi-domain substrate, even if this domain is smaller than the maximum capacity of 
the cavity. Notably, this is exactly what was observed with the putative natural substrate 
hSnu114. The encapsulated fragments had molecular weights between 15 kDa and 45 kDa 
(Figures 32, 35, 36). Thus, it seems likely that partial encapsulation occurs not only for TRiC 
substrates exceeding the size limit, but for most multi-domain substrates with a single TRiC-
dependent domain.  
 
 
Figure 37: Simplified scheme of partial encapsulation of a two-domain protein by TRiC. The two rings 
of TRiC are shown in blue in a side-view, representing two opposite subunits of each ring. The model 
substrate has one TRiC-dependent (yellow) and one TRiC-independent (green) domain, connected by 
a flexible linker. The substrate binds to the apical domain of TRiC (b). Upon ATP hydrolysis the 
TRiC-dependent domain is encapsulated (c). The folded protein is released after ring opening (d). 
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4.2 Factors Influencing Partial Encapsulation 
It is not understood, how the selection of part of a substrate for encapsulation works in molecular 
detail. However, the experiments with actin fusion proteins suggested that the position of a 
domain within a multi-domain protein is influencing its encapsulation. Thus, the mode of 
encapsulation of a domain can be changed by the presence of a neighboring domain as seen for 
hSnu114, whose C-terminal part is completely encapsulated when expressed alone (Figure 33), 
but only partially encapsulated in the context of the full-length protein (Figure 32). 
 
 Initial Binding of Substrates to TRiC 4.2.1
Generally, encapsulation of a substrate is dependent on its initial binding to TRiC. Structural and 
biochemical data indicate that substrate binding to group II chaperonins is mediated by helices 
H10 and H11 within the apical domains of the chaperonin subunits (Pereira et al., 2010; Spiess et 
al., 2006). However, it is still not clear which determinants of the substrate proteins are generally 
mediating the binding to TRiC. It is still a matter of debate whether mainly hydrophobic or 
hydrophilic interactions occur in the initial substrate capturing by group II chaperonins (Huo et 
al., 2010; Jayasinghe et al., 2009; Kubota et al., 2006). 
The interaction of actin with TRiC has been studied in great detail and is an excellent example of 
the complexity of the molecular events associated with substrate recognition, folding and release 
from the eukaryotic group II chaperonin. The tip of subdomain 4 of actin was found to be 
especially important for initial binding of actin to TRiC (McCormack et al., 2001b; Neirynck et 
al., 2006). However, several other regions in the actin molecule have been shown to be involved 
in the interaction with TRiC at later folding stages (Neirynck et al., 2006). Interestingly, a short 
peptide motif within subdomain 1 of actin, which is also present in the TRiC-substrate Cdc20, 
was found to be important for binding of Cdc20 to TRiC (Camasses et al., 2003), suggesting that 
at least some determinants might be of more general importance for TRiC-substrate interactions 
(Neirynck et al., 2006). Nevertheless, no common sequence pattern for prediction of TRiC 
substrates has been identified so far. The present experiments with hSnu114 suggest that the 
binding determinants of this TRiC-interactor are localized within the C-terminal part of the 
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protein (Figures 33, 34, 35). Furthermore, based on the smallest detected fragment of 15 kDa 
(Figures 32b and 35b+d) it is likely that the binding determinants are present in the C-terminal 
140 amino acids. Interestingly, this region is rich in in β-strands (Figure 36b), consistent with 
previously reported data showing enrichment in regions of β-strand propensity among TRiC 
interactors (Yam et al., 2008). 
 
 Sequential Release of Substrates into the TRiC Cavity 4.2.2
The way of encapsulation of a substrate within TRiC is furthermore determined by its release 
into the cavity. In group II chaperonins, release of the substrate was proposed to be mediated by 
a release loop in the apical domain that displaces the substrate bound to the neighboring subunit 
upon closure of the cage (Douglas et al., 2011). As seen for the TRiC-actin complex, substrates 
can interact with more than one TRiC subunit upon initial binding (Llorca et al., 1999a). Subunit 
specific binding across the apical pore might result in disruption of compact, non-productive 
folding intermediates and thus enable subsequent folding. TRiC is a hetero-oligomeric complex 
consisting of eight paralogous subunits. The inter-subunit sequence conservation is especially 
low within the substrate binding region in the apical domains (Kim et al., 1994), suggesting that 
specific TRiC subunits might interact with specific substrates or even specific regions within a 
given substrate. The proposed sequential mechanism of ring-closure (Lin and Sherman, 1997; 
Rivenzon-Segal et al., 2005) would result in a sequential release of the different binding 
determinants of a given substrate from TRiC and thus the encapsulation would occur for every 
substrate individually in a very defined space- and time-dependent manner that might be critical 
for productive folding. 
 
 Position of the TRiC-dependent Domain 4.2.3
It is not yet clear, whether TRiC-dependent domains are preferentially located N- or C-terminally 
or whether no such preference exists. In fact, it is not known, which domains of the known large 
TRiC-interactors are dependent on TRiC for folding. N-terminal TRiC-dependent domains might 
be folded co-translationally by partial encapsulation while the folding of C-terminal domains can 
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be completed only post-translationally. A TRiC-dependent domain in the middle of a large multi-
domain protein would create additional steric constraints because both the N- and the C-terminus 
of the substrate would have to protrude from the cavity and therefore two linker regions would 
have to pass through the opening of the cavity to connect the encapsulated middle-domain with 
the two termini. Indeed, actin as a middle-domain in between an N-terminal BFP and a C-
terminal GFP was not folded by TRiC upon expression in RRL (Figures 13 and 14). However, 
some natural substrates might be evolutionarily optimized for partial encapsulation of a middle-
domain in terms of the linker regions, in contrast to the BFP-actin-GFP construct used here. 
In summary, encapsulation by TRiC is not only influenced by the size of the respective multi-
domain substrate but also by various other factors. The domains adjacent to the TRiC-dependent 
domain in the substrate protein might substantially influence the encapsulation process. For 
example, TRiC encapsulates several different fragments between 15 kDa and 45 kDa of full-
length hSnu114 (Figure 32). In contrast, the complete C-terminal part was encapsulated when it 
was expressed alone (Figure 33). Thus, it appears that the N-terminal part of hSnu114 is 
modulating the encapsulation of the C-terminal part, even though the N-terminal part itself is not 
interacting with TRiC (Figures 31 and 33). Possibly, the N-terminal part serves as a core for 
stepwise addition of C-terminal folding units. The position of the TRiC-dependent domain 
within a multi-domain protein is important for the efficiency of folding. At least, the actin fusion 
proteins that were tested clearly showed context-dependent differences in folding: C-terminal 
actin was more efficiently folded than N-terminal actin. Folding failed completely when actin 
was not localized at either of the termini (Figures 13 and 14). However, it is not clear whether 
this observation can be generalized to natural TRiC substrates. Finally, the complex interplay 
between different binding determinants and the sequential release upon cavity closure is 
accompanied by a high structural flexibility of the open TRiC complex (Cong et al., 2011), 
resulting in heterogeneity of TRiC-substrate complexes upon encapsulation. Heterogeneity of 
encapsulation was observed for the natural substrate hSnu114 (Figures 32 and 35). Digest of the 
TRiC-bound GFP-actin fusion protein resulted mainly in protection of full-length GFP-actin 
because GFP is itself protease-resistant. However, different fragments with the size of actin were 
generated when the linker between GFP and actin was accessible to PK, indicating heterogeneity 
of TRiC-bound GFP-actin as well (Figures 22 and 25). 
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4.3 Structural and Evolutionary Aspects of Partial Encapsulation 
 The Built-in Lid in Group II Chaperonins 4.3.1
Each subunit of a group II chaperonin contains a helical protrusion of approximately 30 amino 
acids at the tip of the apical domain (Klumpp et al., 1997). The protrusions of the different 
subunits come together at the center of the cavity upon ATP hydrolysis to seal off the cavity 
from the surrounding environment, in contrast to group I chaperonins such as GroEL which 
make use of a detachable co-chaperone to close the cage. Conceptually, it is very difficult to 
imagine how partial encapsulation would be achieved if encapsulation occurred with a GroES-
like co-chaperone. By contrast, the iris-like closure of the built-in lid in group II chaperonins is 
perfectly suited for partial encapsulation. The different TRiC subunits would sequentially move 
towards the center of the ring upon ATP hydrolysis, thereby scanning the substrate until they 
reach their final position. The proposed scanning movement of the subunits would also help to 
explain the observed heterogeneity of closed TRiC-substrate complexes. Obviously, the 
flexibility of the different TRiC subunits would not always result in exactly the same portion of 
the substrate to be encapsulated. It is also conceivable that the TRiC complex would not adopt a 
conformation that is as tightly closed as the structures of the symmetrically closed group II 
chaperonins suggest (Cong et al., 2010; Dekker et al., 2011a; Ditzel et al., 1998). However, the 
closure of the cavity is tight enough to prevent protease from accessing parts of the substrate 
inside the cavity as well as to protect the protease-sensitive helical protrusion of TRiC from 
digest, as the experiments with large partially encapsulated substrates show clear protection of 
encapsulated parts. 
 
 Evolution of Different Lids in Group I and II Chaperonins 4.3.2
Based on structural alignments and comparison of the specific tertiary structure of different 
protein folds, it has been proposed that the apical domain of chaperonins originates evolutionary 
from peroxiredoxins (Dekker et al., 2011b). Interestingly, the authors furthermore suggest that 
the Ur-chaperonin was completely lidless and that the development of the different encapsulation 
mechanisms in group I and group II chaperonins took place only after their evolutionary 
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separation rather than that the GroES-like co-chaperone would have been lost during evolution 
of archaea and eukaryotes. If the need for encapsulation of chaperonin-dependent protein-
domains has occurred after the appearance of larger multi-domain proteins in eukaryotes, it is 
logical to assume that only a mechanism of encapsulation like the built-in lid could evolve 
because it was compatible with partial encapsulation. If on the other hand the different 
mechanisms of encapsulation have evolved early after separation of the different kingdoms of 
life, it is clear that larger multi-domain proteins with chaperonin-dependent domains could not 
evolve in eubacteria because their co-chaperone dependent encapsulation mechanism did not 
support partial encapsulation. 
The correlation of the chaperonin type present in a specific domain of life with the proportion of 
multi-domain proteins in that domain suggests a clear interdependency of both factors as long as 
only eubacteria and eukaryotes are analyzed. However, archaea possess group II chaperonins 
with built-in lids, even though their proteomes are very similar to bacterial proteomes with 
regard to the fraction of multi-domain proteins (Ekman et al., 2005). Therefore, it is more likely 
that the folding of large multi-domain proteins by partial encapsulation is not enabled by the 
built-in lid as such, but by the sequential closure of the cavity, which is dependent on the hetero-
oligomeric nature of the eukaryotic chaperonin. Future studies should address, which other large 
TRiC interactors are encapsulated partially by the chaperonin and how partial encapsulation 
works in mechanistic detail.  
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5. Materials and Methods 
5.1 Materials 
 Chemicals 5.1.1
 
Chemical compound Purchased from 
6-aminohexanoic acid Sigma-Aldrich 
Acetic acid Sigma-Aldrich 
Acetone VWR 
ADP Sigma-Aldrich 
Agarose LE Biozyme 
Al(NO3)3 Sigma-Aldrich 
Ampicillin Carl Roth 
APS Sigma-Aldrich 
ATP Sigma-Aldrich 
Bis-Tris methane Sigma-Aldrich 
Bromophenol blue Sigma-Aldrich 
CaCl2 Merck 
Chloramphenicol Sigma-Aldrich 
Cycloheximide Sigma-Aldrich 
DTT Roche 
EDTA Merck 
EDTA-free protease inhibitor cocktail tablets  Roche 
EGTA Sigma-Aldrich 
Glycerol Merck 
Glycine Carl Roth 
HCl VWR 
HEPES Biomol 
Kanamycin Sigma-Aldrich 
KCH3CO2 Carl Roth 
KCl Sigma-Aldrich 
KF Sigma-Aldrich 
KH2PO4 Carl Roth 
β-mercaptoethanol Sigma-Aldrich 
Mg(CH3CO2)2 Merck 
MgCl2 Sigma-Aldrich 
Table 2: List of chemical compounds used in this study. 
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MnCl2 Merck 
MOPS Sigma-Aldrich 
Na2HPO4 Merck 
NaCH3CO2 Sigma-Aldrich 
NaCl VWR 
NaHCO3 Sigma-Aldrich 
(NH4)2SO4 Sigma-Aldrich 
PMSF Sigma-Aldrich 
Ponceau S Sigma-Aldrich 
RbCl Sigma-Aldrich 
SDS SERVA 
Sodium deoxycholate Sigma-Aldrich 
Sucrose Sigma-Aldrich 
SYBR® Safe Invitrogen 
TCEP Thermo Scientific Pierce 
TEMED Sigma-Aldrich 
Trichloroacetic acid Sigma-Aldrich 
Tris Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Tween 20 Sigma-Aldrich 
 
 
 Media and Buffers 5.1.2
 
Medium/Buffer Composition 
LB medium 10 g/l NaCl 
  5 g/l yeast extract (BD) 
10 g/l tryptone (BD) 
Buffer TfB1   30 mM KCH3CO2 
100 mM RbCl 
  50 mM MnCl2 
  10 mM CaCl2 
  15% glycerol 
  Adjust to pH 5.8 with acetic acid 
Buffer TfB2 10 mM MOPS-NaOH, pH 6.8 
10 mM RbCl 
75 mM CaCl2 
15% glycerol 
Table 3: List of media and buffers used in this study. 
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TAE Buffer 40 mM Tris 
40 mM acetic acid 
  1 mM EDTA 
Homogenization Buffer 20 mM HEPES-NaOH, pH 7.4 
50 mM NaCl 
  5 mM MgCl2 
  1 mM EDTA 
  1 mM DTT 
40 tablets/l EDTA-free protease inhibitor cocktail 
Buffer A 20 mM HEPES-NaOH, pH 7.4 
50 mM NaCl 
  5 mM MgCl2 
  1 mM EDTA 
  1 mM DTT 
10% glycerol 
  4 tablets/l EDTA-free protease inhibitor cocktail 
Buffer B 20 mM HEPES-NaOH, pH 7.4 
     1 M NaCl 
  5 mM MgCl2 
  1 mM EDTA 
  1 mM DTT 
10% glycerol 
Storage Buffer   20 mM HEPES-NaOH, pH 7.4 
100 mM NaCl 
    5 mM MgCl2 
    1 mM DTT 
  10% glycerol 
    2 tablets/l EDTA-free protease inhibitor cocktail 
Coupling Buffer 100 mM NaHCO3, pH 8.3 
500 mM NaCl 
Low pH Washing Buffer 100 mM acetic acid / sodium acetate, pH 4.0 
500 mM NaCl 
High pH Washing Buffer 100 mM Tris-HCl, pH 8.0 
500 mM NaCl 
1x PBS 137 mM NaCl 
 2.7 mM KCl 
  10 mM Na2HPO4 
    2 mM KH2PO4 
    pH 7.4 
Dilution Buffer 1x PBS 
5 mM EDTA 
1 mM DTT 
0.1% Tween 20 
20 tablets/l EDTA-free protease inhibitor cocktail 
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Washing Buffer 1   50 mM Tris-HCl, pH 7.4 
150 mM NaCl 
    5 mM EDTA 
    1% Triton X-100 
Washing Buffer 2   50 mM Tris-HCl, pH 7.4 
500 mM NaCl 
    5 mM EDTA 
    1% Triton X-100 
Sucrose Buffer   20 mM HEPES-KOH, pH7.5 
500 mM sucrose 
  10 mM KCl 
    5 mM MgCl2 
    2 mM β-mercaptoethanol 
    1 mM EGTA 
  10% glycerol 
Buffer Lid   20 mM HEPES, pH 7.4 
100 mM KCH3CO2 
    5 mM Mg(CH3CO2)2 
2x SDS Loading Buffer 120 mM Tris-HCl, pH 6.8 
20% glycerol 
5% β-mercaptoethanol 
4% SDS 
0.01% bromophenol blue 
2x Native Loading Buffer 100 mM Bis-Tris methane, pH 8.0 
    1 M 6-aminohexanoic acid 
  10 mM KCl 
    2 mM MgCl2 
  30% glycerol 
  0.008% Ponceau S 
  10 tablets/l EDTA-free protease inhibitor cocktail 
Transfer Buffer 48 mM Tris 
39 mM glycine 
20% methanol 
0.037% SDS 
TBS-T 10 mM Tris-HCl, pH 7.5 
150 mM NaCl 
0.1% Tween 20 
Blocking Buffer TBS-T 
5% skimmed milk powder (Saliter) 
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 Plasmids 5.1.3
The pMS vector was derived from the pCH vector, a modified pET-22b vector (Novagen) 
described earlier by our group (Chang et al., 2005). The vector contains an ampicillin resistance 
gene. The gene of interest is under the control of a T7 promoter. All constructs except 
pMS-ActLink and pMS-ActLink-G150P encoded for proteins with a C-terminal 6xHis-tag.  
 
 
 
Plasmid Encodes for Source 
pMS-BG BFP-L15-GFP-L3-6xHis Markus Stemp 
pMS-A Actin-L9-6xHis Markus Stemp 
pMS-AG Actin-L16a-GFP-L3-6xHis Markus Stemp 
pMS-GA GFP-L17-Actin-L2-6xHis Markus Stemp 
pMS-BAG BFP-L16b-Actin-L16a-GFP-L3-6xHis Markus Stemp 
pMS-BTAG BFP-L23-Actin-L16a-GFP-L3-6xHis Markus Stemp 
pMS-BTAG-G150P BFP-L23-Actin(G150P)- L16a-GFP-L3-6xHis Markus Stemp 
pMS-AL Actin-L17-Luciferase-Xa-L14-myc-6xHis Markus Stemp 
pMS-BGA BFP-L15-GFP-L17-Actin-L2-6xHis This work 
pMS-ActLink Actin-L97 This work 
pMS-ActLink-G150P Actin(G150P)-L97 This work 
pMS-ΔN-GA ΔN-GFP-L17-Actin-L2-6xHis This work 
pMS-AΔN-G Actin-ΔN-GFP-L3-6xHis This work 
 
The actin amino acid sequence used was from Saccharomyces cerevisiae and is accessible under 
the UniProt ID “P60010” (www.uniprot.org). In pMS-BTAG-G150P and pMS-ActLink-G150P, 
glycine at position 150 of actin was mutated to proline. The GFP amino acid sequence used 
differed in five positions from the sequence of wild-type GFP of Aequorea victoria, as described 
under the UniProt ID “P42212”. Specifically, the sequence contained the three cycle 3 mutants 
F99S, M153T and V163A, which reduce the hydrophobicity of GFP and thereby cause less 
aggregation upon heterologous expression (Crameri et al., 1996). Additionally, the GFP 
sequence contains the two point mutations S2G and Q80R compared to the Aequorea victoria 
Table 4: List of actin-fusion expression plasmids used in this study. The linkers between the 
different “domains” are described by “L” followed by the number of amino acids of the respective 
linker. The linker sequences can be found in Table 5. Xa stands for the four amino acid factor Xa 
protease cleavage site “IEGR” (Nagai and Thogersen, 1984). The myc-tag sequence 
“EQKLISEEDL” is indicated by “myc”. 
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sequence, which is a known sequence conflict (see the GFP UniProt entry and the respective 
reference (Rouwendal et al., 1997)). In the constructs with a C-terminal GFP (BG, AG, BAG and 
BTAG), the starting methionine of GFP was exchanged to isoleucine. The BFP sequence 
differed in two positions from the wild-type GFP sequence of Aequorea victoria as described in 
UniProt entry “P42212”. The two mutations are Y66H and Q80R. Y66H is the necessary 
chromophore mutation to convert GFP into BFP (Heim et al., 1994). The luciferase sequence in 
pMS-AL is the sequence from Photinus pyralis, which can be found under the UniProt ID 
“P08659”.  
In order to clone the BGA construct, pMS-BG and pMS-GA were cut with XhoI and DraIII. 
XhoI cuts within the GFP sequence but not within the BFP sequence. DraIII cuts downstream of 
the coding region within the pMS vector. After purification of the respective fragments from an 
agarose gel, a ligation was set up comprising the GFP-actin part of pMS-GA and the BFP-GFP 
part of pMS-BG. The resulting product is pMS-BGA, where the 5' region of the GFP sequence 
originates from pMS-BG and the 3' region of the GFP sequence originates from pMS-GA. 
Construction of pMS-ΔN-GA was started with a PCR reaction to create a respective ΔN-GFP-
actin DNA sequence. pMS-GA was used as plasmid DNA. The respective forward and reverse 
primers were GFPdeltaN38NcoIf and T7Terminator r. Both the PCR product and pMS-GA were 
cut with NcoI and NdeI. The cut PCR product encoding ΔN-GFP was inserted into the cut pMS-
GA construct, thereby replacing wild-type GFP with ΔN-GFP and creating pMS-ΔN-GA. 
In order to generate pMS-AΔN-G, an NcoI restriction site was introduced just upstream of the 
GFP encoding sequence in pMS-AG by site-directed mutagenesis using the primers 
AG G1214C C1217Gfor and AG G1214C C1217Grev. The new pMS-AG that contains the NcoI 
restriction site and pMS-ΔN-GA were both digested with NcoI and XhoI. The fragment 
containing the ΔN-GFP encoding sequence was then inserted into pMS-AG, replacing the wild-
type GFP encoding sequence and thus creating pMS-AΔN-G. 
The ribosome stalling constructs were created by PCR, resulting in a truncated message without 
an in-frame stop codon. AG219 was made using pMS-AG as template DNA. The forward primer 
was T7pIVEX27f that binds 20-40 base pairs upstream of the T7 promoter in the pMS vector. 
The reverse primer was G219r. The resulting PCR product encodes for a truncated nascent chain 
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that will be stalled on the ribosome after incorporation of amino acid 219 of GFP into the 
growing polypeptide. Similarly, the stalling constructs of actin-luciferase were prepared. The 
template DNA was pMS-AL. The forward primer was again T7pIVEX27f for all three stalling 
constructs AL36, AL49 and AL61. The respective reverse primers were Luc36r, Luc49r and 
L61r (Table 7). 
The DNA sequence encoding the 97 amino acid flexible linker for construction of pMS-ActLink 
was synthesized by Sloning Biotechnology GmbH (Puchheim, Germany) and delivered as 
plasmid DNA cloned into the vector pSlo1.1A. After digest of pSlo1.1A_080527 and pMS-AG 
with SpeI and XhoI, the sequence encoding the flexible linker was inserted into the cut pMS-AG 
construct, thereby replacing GFP with the flexible linker and creating pMS-ActLink. pMS-
ActLink-G150P was created by inserting the actin sequence containing the G150P mutation from 
pMS-BTAG-G150P into pMS-ActLink, replacing the wild-type actin sequence, after digest of 
both plasmids with NdeI and SpeI. The stalling constructs ActLink53, ActLink78 and ActLink97 
were obtained by PCR as described above. The forward primer for all three constructs was 
T7pIVEX27f. The respective reverse primers were G4SLinker53r, G4SLinker78r and 
G4SLinker97r. 
The linkers between the different domains in the fusion proteins were based on the sixteen amino 
acid linker L16 (TSGSAASAAGAGEAAA) described previously in context with GFP fusion 
proteins (Chang et al., 2005). The specific linker sequences can be found in Table 5. 
 
Linker Amino acid sequence 
L2 TS 
L3 GAS 
L9 VDKLAAALE 
L14 GSGTSGGSGGSGRS 
L15 SGSAASAAGAGEAAA 
L16a TSGSAASAAGAGEAAA 
L16b SGSAASAAGAGEAAAH 
L17 GASGSAASAAGAGEAAA 
L97 
TSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSAGG
ATVGGGSGGGGSGGGGSGGGGSLLLLNVGGGSGGGGSGGGGIIIIQV 
Table 5: List of linker sequences between “domains” in actin fusion proteins.  
- 86 - 
 
The plasmid DNA, encoding for the different natural TRiC interactors, was obtained from 
different human cDNA libraries containing IMAGE cDNA clones (www.imagenes-bio.de) 
available within the core facility of the Max Planck Institute of Biochemistry (MPIB). I have 
used the following constructs (Table 6). 
 
Gene Name IMAGE ID Vector Promoter 
ATP6V0A1 IRATp970F1251D pCMV-SPORT6 SP6 
COPB2 IRAUp969D082D pOTB7 SP6 
DYNC1H1 IRAUp969G0774D pOTB7 SP6 
EEF2 IRCMp5012E0117D pCR4-TOPO T3 
EFTUD2 IRAUp969B023D pOTB7 SP6 
FASN IRATp970A1078D pCMV-SPORT6 SP6 
GANAB IRATp970G0786D pCMV-SPORT6 SP6 
KIF13A IRCMp5012B0136D pCR-BluntII-TOPO SP6 
LARS IRATp970C01140D pCMV-SPORT6 SP6 
MMS19 IRCMp5012D0412D pCR4-TOPO T3 
MUC17 IRCMp5012B0117D pCR4-TOPO T3 
MYH1 IRCMp5012C1031D pCR-BluntII-TOPO T7 
NUP153 IRATp970E0675D pCMV-SPORT6 SP6 
SKIV2L IRAUp969E0173D pOTB7 SP6 
SMARCC2 IRATp970H0938D pCMV-SPORT6 SP6 
THNSL1 IRATp970D0960D pBluescriptR T7 
TSHZ3 IRCMp5012A1036D pCR-BluntII-TOPO SP6 
UBA1 IRAUp969B0950D pOTB7 SP6 
USP10 IRAUp969G1012D pOTB7 SP6 
 
The constructs for separate expression of the N- and C-terminal parts of β'-COP (β'-COP-N 
(amino acids 1-283) and β'-COP-C (amino acids 284-906)) and hSnu114 (hSnu114-N (amino 
Table 6: Putative TRiC substrates tested for binding to TRiC upon expression in RRL.  
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acids 1-580) and hSnu114-C (amino acids 581-972)) were generated by PCR. The template DNA 
was pOTB7-COPB2 for β'-COP and pOTB7-EFTUD2 for hSnu114, respectively. 
 
In a first PCR reaction, constructs that have the Kozak consensus sequence (Kozak, 1987) 
directly 5' of the start codon and a 12 base pair Poly(A) tail directly 3' of the stop codon were 
created. The respective primer pairs were: 
KozakStartCOPB2(1)for + PolyTStoppCOPB2(283)rev, 
KozakStartCOPB2(284)for + PolyTStoppCOPB2(906)rev, 
KozakStartEFTUD2(1)for + PolyTStoppEFTUD2(580)rev and 
KozakStartEFTUD2(581)for + PolyTStoppEFTUD2(972)rev. 
The respective PCR products were purified from an agarose gel and used as template DNA for 
the second PCR, in which the T7 promoter sequence was added 5' to the Kozak consensus 
sequence. The reverse primers in the second PCR were the same as in the first PCR, but 
T7KozakStartfor was used as a forward primer in all 4 PCRs to add the T7 promoter. 
Two different versions of HA- and FLAG-tagged hSnu114 were created, one with an N-terminal 
HA- as well as a C-terminal FLAG-tag and another one with an N-terminal FLAG- and a C-
terminal HA-tag. In a first step, the sequences of the respective tags were added by PCR. 
pOTB7-EFTUD2 was used as template DNA. The respective primer pairs were: 
FLAG-EFTUD2 for + HA-EFTUD2 rev and HA-EFTUD2 for + FLAG-EFTUD2 rev. 
In order to add a 5' NdeI restriction site and a 3' NheI restriction site, the respective PCR 
products were used as template DNA for a second PCR after purification from an agarose gel. 
The respective primer pairs were: 
Spacer-NdeI-FLAG for + Spacer-NheI-Stop-HA rev and 
Spacer-NdeI-HA for + Spacer-NheI-Stop-FLAG rev 
- 88 - 
 
The PCR products were then cut with NdeI and NheI and inserted into pMS-AG, which was also 
cut with NdeI and NheI, thereby replacing AG with the sequences encoding for the different 
tagged hSnu114 constructs. 
 
 Oligonucleotides 5.1.4
 
Primer Nucleotide sequence (5'→3') Source 
T7pIVEX27f CCGGCGTAGAGGATCGAGATC Florian Brandt 
G219r GGACCATGTGGTCTCTCTTTTC Markus Stemp 
Luc36r GAACCAGGGCGTATCTCTTC This work 
Luc49r TCACCTCGATATGTGCATCTG This work 
L61r GAACGGACATTTCGAAGTATTC Markus Stemp 
G4SLinker53r CCACTGTAGCTCCACCAGC This work 
G4SLinker78r CGACGTTCAGCAGAAGGAG This work 
G4SLinker97r ACACCTGGATGATGATGATGC This work 
GFPdeltaN38NcoIf 
ACTGAGTCCATGGGTTACGGAAAACTT
ACCCTT 
This work 
T7Terminator r GCTAGTTATTGCTCAGCGG This work 
AG G1214C C1217Gfor 
GCTGGCGAAGCGGCCGCCATGGGTAAA
GGAGAAGAACTT 
This work 
AG G1214C C1217Grev 
AAGTTCTTCTCCTTTACCCATGGCGGCCGCT
TCGCCAGC 
This work 
KozakStartCOPB2(1)for 
TAGGGAACAGCCACCATGCCTCTGCGA
CTTGAT 
This work 
PolyTStoppCOPB2(283)rev 
TTTTTTTTTTTTTCATGACCCTCTTAGAC
TGGC 
This work 
KozakStartCOPB2(284)for 
TAGGGAACAGCCACCATGAACAATGTC
GCTTTGGGCT 
This work 
PolyTStoppCOPB2(906)rev 
TTTTTTTTTTTTTCAATCATCCAAAATAT
CTTCATC 
This work 
KozakStartEFTUD2(1)for 
TAGGGAACAGCCACCATGGATACCGAC
TTATATGAT 
This work 
PolyTStoppEFTUD2(580)rev 
TTTTTTTTTTTTTCACAAGGGTCGGAAA
ATCTGA 
This work 
KozakStartEFTUD2(581)for 
TAGGGAACAGCCACCATGAAGTTCAAT
ACCACATCT 
This work 
PolyTStoppEFTUD2(972)rev 
TTTTTTTTTTTTTCACATGGGGTAATTGA
GC 
This work 
Table 7: List of primers used in this study. All oligonucleotides have been purchased from 
metabion international AG (Martinsried, Germany). 
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T7KozakStartfor 
GGATCCTAATACGACTCACTATAGGGA
ACAGCCACCATG 
This work 
FLAG-EFTUD2 for 
CTACAAGGACGACGATGACAAGATGGA
TACCGACTTATATGATG 
This work 
HA-EFTUD2 rev 
GTAGTCTGGGACGTCGTATGGGTACAT
GGGGTAATTGAGCACAAC 
This work 
HA-EFTUD2 for 
ATACGACGTCCCAGACTACGCTATGGA
TACCGACTTATATGATG 
This work 
FLAG-EFTUD2 rev 
GTCATCGTCGTCCTTGTAGTCCATGGGG
TAATTGAGCACAAC 
This work 
Spacer-NdeI-FLAG for 
GAACAGCATATGGACTACAAGGACGAC
GATGAC 
This work 
Spacer-NheI-Stop-HA rev 
GAACAGGCTAGCTTAAGCGTAGTCTGG
GACGTCGTAT 
This work 
Spacer-NdeI-HA for 
GAACAGCATATGTACCCATACGACGTC
CCAGACTAC 
This work 
Spacer-NheI-Stop-FLAG rev 
GAACAGGCTAGCTTACTTGTCATCGTCG
TCCTTGTAG 
This work 
 
 
 
5.2 Molecular Biology Methods 
 Preparation of Chemically Competent Cells 5.2.1
To obtain sufficient amounts of plasmid DNA for subsequent experiments, the respective 
plasmids were multiplied in chemically competent E. coli of the DH5α strain. Chemically 
competent cells were generated with the RbCl method. 3 ml of autoclaved LB medium were 
inoculated with DH5α cells and the cells were incubated for 16 hours overnight at 37°C and 220 
rpm shaking. This culture was diluted 100-fold into 100 ml LB to obtain an OD of approximately 
0.05. The DH5α cells were then incubated again at 37°C and 220 rpm until the OD reached 0.5. 
After incubation for 15 minutes on ice, the cells were centrifuged at 4820 rpm for 15 minutes in 
the C0650 rotor in an Avanti 30 centrifuge (both from Beckman). The pellet was resuspended in 
32 ml buffer TfB1. After 15 min incubation on ice the DH5α cells were again centrifuged for 15 
min at 4820 rpm. The pellet was resuspended in 8 ml buffer TfB2. The resuspended cells were 
divided into aliquots of 50 µl volume, snap-frozen in liquid nitrogen and stored at -80°C. 
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 Transformation of Chemically Competent Cells 5.2.2
Transformation of the chemically competent cells was performed by the following procedure: A 
50 µl aliquot of DH5α cells was thawed on ice for 10 min. Then 1 µl of plasmid DNA with a 
concentration of 15 ng/µl (in H2O) was added. After 30 min incubation on ice, the DH5α cells 
were heat-shocked at 42°C for 45 sec. After 2 min incubation on ice, 800 µl LB medium was 
added and the cells were incubated for 1 h at 37°C under shaking at 600 rpm. The cells were then 
pelleted by centrifugation at 16100 g for 15 sec. 650 µl of the supernatant were removed, the 
pellet was resuspended in the remaining supernatant and distributed on an LB agar plate 
containing the respective antibiotic. The plate was incubated at 37°C for 16 h. 
 
 Preparation of Plasmid DNA 5.2.3
To amplify plasmid DNA, a single colony was used to inoculate 3 ml LB medium containing 
100 µg/ml ampicillin or 10 µg/ml kanamycin, or 25 µg/ml chloramphenicol depending on the 
resistance conferred by the respective plasmid. 
For a Miniprep, the cells were grown for 16 h at 37°C and 220 rpm shaking. The Minipreps were 
done using the Wizard® Plus SV Minipreps DNA Purification System from Promega according 
to the manufacturer’s instructions, except that addition of Alkaline Protease Solution, which was 
interfering with subsequent in vitro translation reactions, was omitted. Elution from the Spin 
Columns was generally done with 50 µl H2O. 
For a Midiprep, the cells were incubated for 8 h at 37°C and 220 rpm shaking after inoculation of 
3 ml LB-ampicillin. Then 100 µl were diluted into 50 ml LB-ampicillin and incubated for 16 h at 
37°C and 220 rpm shaking. The Midiprep was done using the PureYield™ Plasmid Midiprep 
System from Promega according to the manufacturer’s instructions. Elution from the 
PureYield™ Binding Column was generally done with 550 µl H2O. The DNA concentration was 
determined by absorbance at 260 nm using the NanoDrop 1000 spectrophotometer (Thermo 
Fisher Scientific). Plasmid DNA was stored at -20°C. 
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 Gel Electrophoresis of DNA 5.2.4
Gel electrophoresis of DNA was generally done for 20 min at 90 V using 1% agarose LE gels in 
TAE buffer (Table 3). For visualization of DNA, SYBR® Safe was diluted 1:10000 into the gel 
mixture. As a molecular weight marker, GeneRuler™ 1 kb DNA Ladder from Fermentas was 
used. Visualization was done using a UV-transilluminator system from MVG-Biotech and the 
BioCaptMW software. When DNA fragments were to cut from the agarose gel for subsequent 
applications, the Safe Imager™ 2.0 Blue Light Transilluminator from Invitrogen was used. 
Purification of DNA from agarose gel slices was done using the Wizard® SV Gel and PCR 
Clean-Up System from Promega according to the manufacturer’s instructions. 
 
 Polymerase Chain Reaction 5.2.5
Generally, PCR reactions were performed in a volume of 50 µl and contained 15 ng template 
DNA. The final concentration of each primer was 400 nM and the final concentration of each 
dNTP was 200 µM. As polymerase, generally Herculase Enhanced DNA Polymerase from 
Stratagene was used at a final concentration of 0.1 U/µl. The PCR reactions were done in a T3 
Thermocycler from Biometra. An initial denaturation step was included in all PCR conditions for 
3 min at 95°C. Within each cycle, the denaturation step was generally at 95°C for 30 sec, the 
annealing temperature was dependent on the respective primers and was generally between 50-
60°C for 30 sec, and the elongation step was at 72°C for 1 min per kb of expected PCR product. 
Generally, each cycle was repeated 30-35 times, followed by a final elongation step at 72°C that 
was approximately 1.5 times as long as the elongation step within the cycle. For site directed 
mutagenesis, the cycle was typically repeated only 15 times. PCR purification was done using 
the Wizard® SV Gel and PCR Clean-Up System from Promega according to the manufacturer’s 
instructions. 
 
 Restriction Digest 5.2.6
All restriction enzymes were purchased from New England Biolabs. Restriction digests were 
done in a final volume of 10 µl containing typically 1-2 µg DNA in the buffer best suited for the 
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respective restriction enzymes (NEBuffer 1, 2, 3 or 4, New England Biolabs). When suggested 
for the respective restriction enzymes, the reactions contained additionally 100 µg/ml BSA. 
Normally, 0.5 µl of each restriction enzyme were used. The reactions were incubated at 37°C for 
90 min. When the respective fragment was to be used as the vector in a subsequent ligation, the 
reaction was incubated for another 30 min at 37°C after addition of 5 units of Calf Intestinal 
Alkaline Phosphatase (New England Biolabs) to prevent vector re-ligation. 
 
 DNA Ligation 5.2.7
Ligation was done after purification of the respective fragments from agarose gels. The total 
volume of a ligation reaction was 10 µl and the ligation was done in T4 DNA Ligase Reaction 
Buffer (New England Biolabs). The molar insert:vector ratio was typically 3-5 and the total 
DNA mass in the reaction was normally 100-150 ng. Generally, a ligation reaction contained 200 
cohesive end units T4 DNA Ligase, purchased either from New England Biolabs or from the 
core facility of MPIB. The ligation reactions were incubated for 40 min at room temperature 
followed by incubation for 40 min at 4°C. Prior to transformation of chemically competent 
DH5α, the T4 DNA ligase was inactivated by incubation at 60°C for 10 min. Typically, 2.5 µl of 
a ligation reaction were used for transformation of 50 µl DH5α. 
The DNA sequence of all constructs was verified by DNA sequencing in the Core Facility of 
MPIB. 
 
 
5.3 Biochemical Methods 
 Purification of TRiC from Bovine Testes 5.3.1
TRiC from bovine testes was purified with minor modifications following a published protocol 
(Villebeck et al., 2007b). The whole purification procedure was performed at 4°C. 200 g bovine 
testes were homogenized in 300 ml homogenization buffer. Homogenization was done using the 
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PT-DA 3012/2TM dispersing tool connected to the POLYTRON PT 3100 homogenizer (both 
from Kinematica) with up to 6000 rpm. The homogenate was clarified by centrifugation at 
20,000 g for 40 min using the JA 25.50 rotor in an Avanti™ J-25I centrifuge (both from 
Beckman) at 4°C. The supernatant was further processed by ultracentrifugation at 118,000 g for 
60 minutes using the Type 70 Ti rotor in an Optima™ L-90K centrifuge (both from Beckman) at 
4°C. 
Salt fractionation: ATP was added to a final concentration of 1 mM to the supernatant. 
Subsequently, a saturated stock solution of (NH4)2SO4 was added to the supernatant to 25% 
saturation (3 parts supernatant + 1 part (NH4)2SO4 stock solution). Precipitated material was 
removed by centrifugation at 20,000 g for 30 min at 4°C using the JA 25.50 rotor in an Avanti™ 
J-25I centrifuge. Then (NH4)2SO4 was added to 55% saturation to the supernatant (6 parts 
supernatant + 4 parts (NH4)2SO4 stock solution). Precipitated material was sedimented by 
centrifugation at 20,000 g for 40 minutes at 4°C using the JA 25.50 rotor in an Avanti™ J-25I 
centrifuge. The resulting pellet was resuspended in 70 ml buffer A. Insoluble material was 
removed by centrifugation at 20,000 g for 20 minutes at 4°C. 
Heparin chromatography: Before loading the supernatant onto a HiTrap™ Heparin HP column 
(GE Healthcare) ATP was added to a final concentration of 1 mM. Five 5 ml HiTrap™ Heparin 
HP columns were connected in series to an ÄKTA™purifier system (GE Healthcare). The 
columns were equilibrated in buffer A (Table 3). After loading the supernatant onto the columns, 
a wash step with 40 ml of 12% buffer B (Table 3) was applied. Then, a gradient from 12% buffer 
B to 25% buffer was applied within the next 30 ml. Another gradient from 25% buffer B to 60% 
buffer B was applied within the next 200 ml. Finally, the column was washed with another 50 ml 
of 100% buffer B. 9 fractions of 8 ml volume each were collected during the initial washing until 
25% buffer B was reached. Then fractions of 5 ml each were collected during the gradient from 
25-60% buffer B and during the final wash with 100% buffer B. TRiC eluted in fractions 40-55 
towards the end of the 25-60% buffer B gradient, as judged by a dot blot probed with an 
antibody against CCTα. The respective fractions were further analyzed by SDS-PAGE followed 
by Coomassie staining. Most TRiC was found in fractions 47-53 and thus these fractions were 
pooled. 
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Size exclusion chromatography: Before loading onto a HiLoad™ 16/60 Superdex 200 gel 
filtration column (GE Healthcare), the pooled fractions were concentrated to a final volume of 
7 ml using a Vivaspin 20 centrifugal concentrator (Sartorius) with a molecular weight cutoff of 
100 kDa. The column was equilibrated and run with storage buffer. Fractions of 4 ml volume 
were collected and analyzed by SDS-PAGE followed by Coomassie staining. TRiC was eluting 
in fractions 11-13. Thus, fractions 11-13 were pooled and concentrated with a Vivaspin 20 
centrifugal concentrator to a final volume of 3 ml. 
The concentration of TRiC was determined using the Coomassie Protein Assay Kit (Thermo 
Scientific Pierce), which works based on the assay described by Bradford (Bradford, 1976). The 
final concentration of the TRiC preparation was approximately 4.7 mg/ml, which corresponds to 
5 µM. Thus, in total approximately 14 mg of TRiC were obtained from 200 g of bovine testes. 
The purified TRiC was stored in aliquots at -80°C. 
 
 In vitro Translation in Rabbit Reticulocyte Lysate 5.3.2
Different TNT
®
 Coupled Reticulocyte Lysate Systems by Promega were used depending on the 
expression construct. All of these systems were coupled transcription/translation systems based 
on a lysate of rabbit reticulocytes. Plasmid DNA that was to be transcribed by the T7 RNA 
polymerase or the SP6 RNA polymerase was typically expressed using the TNT
®
 T7 Quick 
Coupled Transcription/Translation System or the TNT
®
 SP6 Quick Coupled 
Transcription/Translation System, respectively. Plasmid DNA that was to be transcribed by the 
T3 RNA polymerase was expressed using the TNT
®
 T3 Coupled Reticulocyte Lysate System. 
Finally, when PCR products served as DNA source instead of plasmids, TNT
®
 T7 Quick for 
PCR DNA was used for expression. 
Generally, the coupled transcription/translation reactions were done at 30°C using the 
Thermomixer Comfort 1.5 ml (Eppendorf) in a total volume of 50 µl containing 1 µg of DNA. 
The protein of interest that was produced was typically radioactively labeled by addition of 
10 µCi of EasyTag™ L-[35S]-Methionine (PerkinElmer). 
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 Depletion of TRiC from Rabbit Reticulocyte Lysate 5.3.3
To investigate the TRiC dependence of actin folding in RRL, TRiC was depleted from RRL 
using the high affinity TRiC interactor PhLP1. Human PhLP1 was purified upon overexpression 
in BL21 E. coli cells (provided by Markus Stemp). The protein contains additionally the 
following 27 N-terminal amino acids, including a 6xHis-tag and a TEV cleavage site: 
MSYYHHHHHHDYDIPTTENLYFQGAMG. The purified protein had a concentration of 11.3 
mg/ml. PhLP1 was coupled to Dynabeads
®
 TALON™ via its N-terminal 6xHis-tag. The PhLP1 
buffer contained DTT, which is suggested to be removed prior to coupling to Dynabeads
®
 
TALON™ (Invitrogen) by the manufacturer. Therefore, buffer exchange to PBS was done using 
Micro Bio-Spin
®
 columns filled with Bio-Gel
®
 P-6 (both from Bio-Rad) according to the 
manufacturer’s instructions. 500 µl Dynabeads® TALON™ solution with a concentration of 40 
mg/ml were washed three times with 1.5 ml PBS. Separation of the beads from the supernatant 
was possible by immobilizing the beads on one side of a reaction tube using a magnet. Then the 
beads were resuspended in 700 µl PBS, mixed with 60 µl of PhLP1 and incubated for 2 h at 4°C 
rotating with 11 rpm. After three washes with each 1.5 ml PBS to remove unbound PhLP1, the 
PhLP1-beads were resuspended in 500 µl PBS and stored at 4°C. For depletion of TRiC from 
RRL, the beads were washed twice with 1 ml RNase free H2O. Then the beads were incubated 
with 125 µl TNT
®
 Rabbit Reticulocyte Lysate for 2 h at 4°C rotating with 11 rpm. 
Simultaneously, a control TNT
®
 Rabbit Reticulocyte Lysate was kept at 4°C for 2 h. Both lysates 
were subsequently used for translation reactions. Samples of untreated and depleted RLL were 
taken to monitor the depletion efficiency by Western Blot using an antibody against CCTα. To 
check if actin folding was restorable by addition of purified TRiC, half of the depleted translation 
reactions were supplemented with 1 µM purified bovine TRiC prior to translation. 
 
 Preparation of DNase I - Sepharose 5.3.4
DNase I (grade II from bovine pancreas, Roche) was coupled to CNBr-activated Sepharose™ 4B 
(GE Healthcare). 1 g of CNBr-activated Sepharose™ 4B powder was hydrated in 10 ml of 1 mM 
HCl, yielding approximately 3.5 ml Sepharose medium. The medium was washed three times by 
centrifugation for 2 min at 1000 rpm in a GH-3.8 rotor in a GS-6R centrifuge (both from 
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Beckman) and removal of the supernatant followed by addition of 10 ml fresh 1 mM HCl. 
DNase I was dissolved in 5 ml coupling buffer and added to the washed Sepharose medium. The 
mixture was incubated by constant rocking at room temperature for 90 min. The DNase I beads 
were subsequently washed three times with 10 ml coupling buffer. The excessive amine binding 
sites were blocked by incubation for 2 h with 10 ml of 100 mM Tris-HCl, pH 8.0 at room 
temperature without rocking. Then the DNase I beads were washed three times with alternating 
low pH and high pH buffer (10 ml each). The washed beads were stored in 20% ethanol at 4°C. 
 
 DNase I Binding Assay 5.3.5
Typically, the DNase I binding assay was performed with 3-6 RRL reactions in parallel that were 
translating different constructs. 150-300 µl of a 1:1 suspension of DNase I beads were used 
depending on the number of RRL reactions to be processed. The beads were washed two times 
with 1 ml dilution buffer  by centrifugation at 1,000 g for 3 min at 4°C using an FA-45-24-11 
rotor in a 5415 R centrifuge (both from Eppendorf) followed by removal of the supernatant and 
addition of fresh buffer. Finally, the beads were resuspended in 75-150 µl dilution buffer 
depending on the initial volume of beads in order to restore a 1:1 suspension. The translation 
reaction in the 50 µl RRL mixtures was stopped after 90 min by addition of 0.5 U apyrase (grade 
VII from potato, Sigma-Aldrich) followed by incubation at 30°C for 2 min. A 4 µl sample was 
taken as an input reference and diluted into 26 µl of 2x SDS loading buffer. 40 µl of the RRL 
reaction were diluted into 400 µl dilution buffer and subsequently mixed with 40 µl of the 1:1 
suspension of washed DNase I beads. After continuous rocking at 4°C for 2 h, the beads were 
washed with 500 µl dilution buffer, 500 µl washing buffer 1, 2 x 500 µl washing buffer 2 and 
finally with 500 µl PBS using a Mobicol “classic” spin column (Mobitec) connected to a QIAvac 
24 vacuum manifold (QIAGEN). After a short spin (3 sec, 5,000 rpm using an FA-45-24-11 
rotor in a 5415 D centrifuge (both from Eppendorf)) to remove excessive buffer, the proteins 
bound to the beads were eluted with 30 µl 2x SDS loading buffer by incubation for 2 min at 
95°C followed by centrifugation at 16,100 g for 2 min, resulting in an effective ten-fold higher 
concentration of the eluate sample compared to the input sample. 12 µl of both the input and the 
eluate samples were analyzed by SDS-PAGE followed by autoradiography. 
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DNase I binding of BTAG: In case of translation of the cleavable BTAG construct, translation 
was stopped after 90 min either by addition of 0.5 U apyrase or by addition of cycloheximide  to 
a final concentration of 140 µM. A 4 µl sample was taken to ensure that full-length BTAG was 
indeed made. The reaction was then incubated with a final concentration of 500 U/ml TEV 
protease (Invitrogen) for 30 min at 30°C followed by the DNase I binding assay as described. 
DNase I binding after separating stalled and free nascent chains: In order to separate stalled 
ActLink78 and ActLink97 nascent chains from free released chains prior to DNase I binding, 
centrifugation through a sucrose cushion was used. After translation at 30°C for 60 min the 
translation was stopped by addition of 0.5 U apyrase and incubation for 2 min at 30°C. After 
taking a 2 µl total sample, 20 µl of the RRL reactions were added on top of 130 µl sucrose buffer 
in a 7x20 mm Open-Top Thickwall Polycarbonate Tube (Beckman). After centrifugation at 
75,000 rpm for 60 min using a TLA-100 rotor in an Optima TLX centrifuge (both from 
Beckman) the supernatant (150 µl) was removed and the pellet was resuspended in 150 µl 
sucrose buffer. After taking a 12 µl input sample from both the supernatant and the resuspended 
pellet fraction, 120 µl of the respective fractions were diluted into 400 µl dilution buffer. 
DNase I binding was done as described above using 40 µl washed DNase I beads. 
 
 Protease Protection Assay 5.3.6
PK protection of purified TRiC: PK digest of purified bovine TRiC was done in buffer lid 
(Table 3) that was described previously by Booth et al., 2008. TRiC was diluted 1:20 into buffer 
lid containing 1 mM TCEP yielding a final TRiC concentration of 250 nM in a total volume of 
50 µl. In order to convert TRiC into defined conformational states, TRiC was incubated at 30°C 
in presence of either 1 mM ADP or 1 mM ATP or without addition of any nucleotide. As a 
control, one reaction contained 10 mM EDTA in addition to 1 mM ATP. After 30 min ADP or 
ATP was added to a final concentration of 2 mM to the reactions containing the respective 
nucleotide. AlFx was produced by adding KF to a final concentration of 30 mM and Al(NO3)3 to 
a final concentration of 5 mM. After incubation for another 60 min at 30°C each reaction was 
split into two parts and transferred to ice. One part served as an input control. The other was 
incubated in presence of a final concentration of 83 ng/µl PK for 10 min on ice. The input 
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control received the same volume of H2O instead of PK. The protease was inactivated by 
addition of PMSF to a final concentration of 8 mM. The samples were diluted into 2x SDS 
loading buffer prior to SDS-PAGE and into 2x native loading buffer prior to native PAGE. 
PK protection of proteins translated in RRL: PK digest of RRL translation reactions was done 
under varying conditions. For quantification of the intensity of the protease-resistant 35 kDa 
actin fragment, the digest was done after translation of the respective constructs for 90 minutes at 
30°C. Translation was stopped by addition of cycloheximide to a final concentration of 140 µM 
followed by incubation at 30°C for 2 min. Typically, RRL reactions were incubated at 30°C for 
30-60 min prior to addition of AlFx, which was done as described above. Control reactions 
received the same volume of H2O instead of AlFx. Generally, the reactions were kept at 30°C for 
another 30-60 min before they were split into two parts and transferred to ice. The PK digest was 
done as described above for purified TRiC.  
Analysis of PK protection of TRiC-bound proteins: Elution of TRiC-bound proteins from 
native gels was achieved by incubation of TRiC-containing gel slices in 150 µl 2x SDS loading 
buffer without SERVA Blue R for 2 hours at 68°C and 1,400 rpm shaking in the Thermomixer 
Comfort 1.5 ml followed by incubation at 95°C for 10 min and centrifugation for 10 min at 
16,100 g using the FA-45-24-11 rotor in the 5415 D centrifuge. The TRiC-containing regions of 
the native gel were identified after Coomassie staining and comparison with the position of 
purified bovine TRiC run in parallel as control. Typically, the eluted proteins were precipitated 
prior to analysis by SDS-PAGE. 125 µl of the 2x SDS loading buffer containing the eluted 
proteins was incubated on ice in presence of 0.02% sodium deoxycholate for 45 min. Then 
trichloroacetic acid was added to a final concentration of 10% and the mixture was incubated for 
another 75 min on ice. After centrifugation at 16,100 g using the FA-45-24-11 rotor in the 5415 
R at 4°C for 20 min, the supernatant was discarded and the pellet was resuspended in 180 µl ice-
cold (-20°C) acetone and kept at -20°C for 15 min. After another centrifugation at 16,100 g for 
15 min at 4°C, the supernatant was again discarded and the pellet was resuspended in 20 µl 2x 
SDS loading buffer. 15 µl of the sample were analyzed by SDS-PAGE. 
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 Native PAGE Mobility Shift Assay 5.3.7
To detect a mobility shift in native PAGE, RRL reactions translating actin, GFP-actin or ΔN-
GFP-actin were incubated with an anti-GFP antibody (Roche). The antibody provided by Roche 
is actually a mixture of two monoclonal antibodies (clones 7.1 and 13.1). The different 
translation reactions were either treated with AlFx as described above or received the 
corresponding volume of H2O instead of AlFx. 45-60 min after addition of AlFx or H2O the 
samples were transferred to ice and incubated in presence of 10 ng/µl anti-GFP for 90 min. Then 
the samples were split into two parts for PK digest as described above. Prior to SDS-PAGE and 
native PAGE, parts of the samples were diluted into the respective loading buffers. Samples that 
were treated with AlFx were analyzed by Blue Native PAGE containing 30 mM KF and 5 mM 
Al(NO3)3 within the native gel as well as within the cathode and anode buffer. Samples that were 
not treated with AlFx were analyzed by Clear Native PAGE without any AlFx. 
 
 Electrophoresis of Proteins 5.3.8
A discontinuous (Davis, 1964; Ornstein, 1964) SDS polyacrylamide gel system was used similar 
in composition to the one described by Laemmli (Laemmli, 1970). The composition of the 
electrode buffer and of the separating gel was exactly as described. The stacking gel used had a 
higher acrylamide concentration than the one of Laemmli, namely 5% compared to 3% and a 
lower concentration of Tris, namely 60 mM instead of 125 mM. The 30% acrylamide stock 
solution was purchased from SERVA and contained acrylamide and N,N’-
Methylenebisacrylamide in a 37.5:1 ratio. Polymerization was done with 0.0625% APS and 
0.0625% TEMED in case of the separating gel and with 0.05% APS (Sigma-Aldrich) and 0.1% 
TEMED (Sigma-Aldrich) in case of the stacking gel. SDS-PAGE was normally done with an 
initial voltage of 120 V for 10 min followed by another 50 minutes with 180 V. 
Native PAGE was also done using a discontinuous system similar to the one described by 
Schägger and von Jagow (Schagger and von Jagow, 1991). Native PAGE was performed at 4°C 
with an initial voltage of 100 V for 2 h followed by 14-16 h at 200 V. The composition of the 
anode buffer as well as the gel buffer was exactly as described. The cathode buffer was identical 
to cathode buffer A described by Schägger and von Jagow except for the Bis-Tris concentration, 
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which was 12 mM. Typically, electrophoresis was done as Clear Native PAGE, thus omitting 
SERVA Blue G in the cathode buffer. The dimensions of the gels were 20 cm x 20 cm x 1 mm. 
The bottom of the gel was plugged by 2 ml of a 9% acrylamide solution (0.6 ml of the 30% 
acrylamide stock solution + 1.4 ml H2O) polymerized by 0.1% APS and 0.1% TEMED to avoid 
leaking of liquid upon pouring the separating gel. The separating gel formed a continuous 
gradient from 13% acrylamide at the bottom to 5% acrylamide on top. The gradient was 
produced by mixing two different solutions of 12 ml volume each using the gradient maker 
SG50 (Hoefer). The solution that was filled into the chamber closer to the outlet valve contained 
13% acrylamide and approximately 17% glycerol in gel buffer plus 0.035% APS and TEMED 
for polymerization. The solution that was filled into the other chamber contained 5% acrylamide 
and 5% glycerol in gel buffer plus approximately 0.048% APS and TEMED for polymerization. 
After the outlet valve and the valve connecting the two chambers were opened, the solutions 
were pumped into the assembled glass plates using the peristaltic Pharmacia pump LKB P-1, 
thus forming the continuous gradient. During the pumping, the solutions were continuously 
mixed by magnetic stirring bars. After polymerization of the separating gel, 5 ml stacking gel 
were added on top of the gradient separating gel. The stacking gel contained 3.25% acrylamide 
in gel buffer. 
Typically, 6 mM KF and 1 mM Al(NO3)3 were included in the gel buffer as well as the anode 
and cathode buffer, in order to prevent opening of TRiC complexes during the gel run, which had 
been pre-treated with AlFx. However, gels were also run in absence of AlFx. Additionally, in 
case of the antibody gel shift assay, gels were run including 30 mM KF and 5 mM Al(NO3)3 in 
gel buffer and anode and cathode buffer to ensure complete closure of TRiC complexes during 
the gel run. In this case the native gel had to be run as Blue Native PAGE to obtain separation of 
appropriate quality. 
Both SDS gels and native gels were stained as follows. The gels were subjected to constant 
shaking during the whole staining and destaining procedure. Coomassie staining of gels was 
done using 0.25% SERVA Blue R in 45% ethanol and 10% acetic acid generally for 
approximately 30 min at room temperature. Destaining was done using destain solution (10% 
acetic acid, 40% ethanol) at room temperature for several hours. The gel was then incubated in 
H2O for at least 15 min prior to scanning using the Epson Expression 1680 scanner. Incubation 
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with H2O was also done prior to excision of slices from native gels for subsequent elution of 
proteins from TRiC-containing slices. 
When the gel was to be analyzed by autoradiography only, the staining, destaining and watering 
procedure was substantially shortened to approximately 5-10 min for each step. The gel was then 
dried at 76°C for 1 h (SDS gels) or 2 h (native gels) using an SGD 2000 slab gel dryer embedded 
in an SGD 300 stacker gel dryer system (both from Savant). A BAS-MS 2025 imaging plate 
(Fujifilm) was then exposed to the dried gel for varying times in an FBXC 810 autoradiography 
cassette (Fisher Biotech), generally between 1 and 24 h depending on the intensity of the signal. 
The signal was recorded using the FLA-2000 scanner (Fujifilm) and analyzed using the AIDA 
software version 4.15 (raytest). 
 
 Western Blotting 5.3.9
If proteins were to be detected by specific antibodies after native PAGE or SDS-PAGE, they 
were transferred electrophoretically to a Protran™ nitrocellulose membrane (Whatman). 
Transfer of proteins from SDS gels was done using a Mini Trans-Blot Cell (Bio-Rad) filled with 
transfer buffer. Typically, the transfer was done for 1 h using 200-300 mA per gel. Proteins from 
native gels were transferred by semi-dry transfer for 1 h using 0.8 mA per cm
2
 of gel. Prior to 
transfer, native gels were incubated for 30 min in transfer buffer containing additional 0.2% 
SDS. 
After transfer, the nitrocellulose membranes were blocked by incubation in blocking buffer, 
generally for approximately 30 min at room temperature. Primary and secondary antibodies were 
diluted into blocking buffer as well, prior to incubation with the nitrocellulose membrane. The 
incubation of the membrane with the respective antibodies was done in a rotating chamber to 
ensure even coverage of the membrane with the antibody solution. Incubation with the primary 
antibody was done for approximately 16 h at 4°C or alternatively for approximately 2 h at room 
temperature. The nitrocellulose membrane was washed three times with TBS-T between 
incubations with primary and secondary antibody. Typically, the membrane was incubated with 
secondary antibody for approximately 2 h at room temperature. Prior to detection, the membrane 
was washed three times with TBS-T. Secondary antibodies coupled to horseradish peroxidase 
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were used. For detection, the membrane was incubated with the USB Rodeo™ ECL Detection 
Reagents (Affymetrix). The emitted light was detected using the LAS-3000 imaging system 
(Fujifilm). 
TRiC was detected using a rat monoclonal antibody directed against CCTα (CTA-191, 
Stressgen) at a final concentration of 1 µg/ml. The HA-tagged hSnu114 was detected using a rat 
monoclonal anti-HA antibody (Anti-HA High Affinity, clone 3F10, Roche) at a final 
concentration of 0.2 µg/ml. Both primary antibodies were detected by anti-rat IgG (whole 
molecule) peroxidase conjugate (A 9037, Sigma-Aldrich) diluted 1:1000 into blocking buffer. 
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7. Abbreviations 
ADP  Adenosine 5'-diphosphate 
AlFx  Aluminum fluoride 
AMP-PNP Adenosine 5'-(β,γ-imido)triphosphate 
APS  Ammonium persulfate 
ATP  Adenosine 5'-triphosphate 
ATPγS  Adenosine 5'-(γ-thio)triphosphate 
BFP  Blue Fluorescent Protein 
BSA  Bovine Serum Albumin 
CCT  Chaperonin Containing TCP-1 
cDNA  complementary DNA 
CHO  Chinese Hamster Ovary 
DM-MBP Double Mutant form of Maltose Binding Protein 
DNA  Deoxyribonucleic Acid 
DNase  Deoxyribonuclease 
dNTP  Deoxyribonucleotide 
DTT  Dithiothreitol 
EDTA  Ethylenediaminetetraacetic acid 
EGTA  Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
EM  Electron Microscopy 
FL  Full-Length 
FRET  Förster Resonance Energy Transfer 
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GDP  Guanosine 5'-diphosphate 
GFP  Green Fluorescent Protein 
GTP  Guanosine 5'-triphosphate 
HA  Hemagglutinin 
HEPES  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
Hsp  Heat Shock Protein 
IgG  Immunoglobulin G 
LB  Lysogeny Broth 
Mm-cpn Methanococcus maripaludis Chaperonin 
MOPS  3-(N-Morpholino)propanesulfonic acid 
MPIB  Max Planck Institute of Biochemistry 
mRNA  messenger RNA 
NAC  Nascent chain Associated Complex 
NBD  Nucleotide Binding Domain 
NEF  Nucleotide Exchange Factor 
OD  Optical Density 
PAGE  Polyacrylamide Gel Electrophoresis 
PBS  Phosphate Buffered Saline 
PCR  Polymerase Chain Reaction 
PDB  Protein Data Bank 
PFD  Prefoldin 
PhLPs  Phosducin-Like Proteins 
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PK  Proteinase K 
PMSF  Phenylmethanesulfonyl fluoride 
PTC  Peptidyl Transferase Center 
RAC  Ribosome Associated Complex 
RNA  Ribonucleic Acid 
rpm  Revolutions Per Minute 
RRL  Rabbit Reticulocyte Lysate 
SAXS  Small Angle X-ray Scattering 
SDS  Sodium Dodecyl Sulfate 
SGA  Synthetic Genetic Array 
SHR  Steroid Hormone Receptor 
snRNA  small nuclear RNA 
TAE  Tris-Acetate-EDTA 
TCP-1  T-Complex Polypeptide-1 
TEMED Tetramethylethylenediamine 
TEV  Tobacco Etch Virus 
TF  Trigger Factor 
TRiC  TCP-1 Ring Complex 
Tris  Tris(hydroxymethyl)aminomethane 
tRNA  transfer RNA 
VHL  von Hippel-Lindau 
 
